Document:

EX-10.17

 Exhibit 10.17 

DATED: June 1, 2011 

SONY DADC AUSTRIA AG 
 -
and - 
 RAINDANCE TECHNOLOGIES, INC. 

SUPPLY AGREEMENT 

providing for the supply of microfluidic polymer 

chips for oil emulsion droplet sampling 
  

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 INDEX 
  

									
	 1.      PRELIMINARY
	  	 	1	  
		 	1.1	 	Definitions	  	 	1	  
		 	1.2	 	Interpretation	  	 	5	  
		
	 2.      APPOINTMENT
	  	 	5	  
		 	2.1	 	Exclusive Appointment	  	 	5	  
		 	2.2	 	Permitted Third Party Supply	  	 	6	  
		 	2.3	 	Restriction on Other Relationships	  	 	6	  
		 	2.4	 	Restriction on MPC Development, Manufacture and Sale	  	 	7	  
		 	2.5	 	Provisos.	  	 	7	  
		 	2.6	 	Preferred Manufacturing Partner Status	  	 	7	  
		 	2.7	 	IP Disclaimer	  	 	8	  
		 	2.8	 	Revenue Threshold	  	 	8	  
		
	 3.      FORECASTING
	  	 	9	  
		 	3.1	 	Information and Consultation	  	 	9	  
		 	3.2	 	Forecasts	  	 	9	  
		 	3.3	 	Status of Forecasts	  	 	9	  
		
	 4.      PURCHASE ORDERS
	  	 	10	  
		 	4.1	 	Issue	  	 	10	  
		 	4.2	 	Acceptance	  	 	11	  
		 	4.3	 	Confirmation	  	 	11	  
		 	4.4	 	Minimum Shipment Quantities	  	 	11	  
		 	4.5	 	Purchase Contracts	  	 	11	  
		
	 5.      MANUFACTURE OF THE PRODUCTS
	  	 	11	  
		 	5.1	 	Specification	  	 	11	  
		 	5.2	 	Compliance with Laws	  	 	12	  
		 	5.3	 	Permitted Use	  	 	12	  
		 	5.4	 	Packaging	  	 	13	  
		 	5.5	 	Manufacturing Undertakings	  	 	13	  
		 	5.6	 	Safety Stock	  	 	14	  
			
	6.	 	DELIVERY	  	 	15	  
		 	6.1	 	Delivery	  	 	15	  
		 	6.2	 	Shipment	  	 	15	  
		 	6.3	 	Delivery Date	  	 	15	  
		 	6.4	 	Inspection and Acceptance	  	 	16	  
			
	7.	 	RISK AND TITLE	  	 	17	  
		 	7.1	 	 Risk      
	  	 	17	  
		 	7.2	 	 Title     
	  	 	17	  

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

									
	8.	 	PRICE	  	 	18	  
		 	8.1	 	Payment Obligation	  	 	18	  
		 	8.2	 	Initial Price	  	 	18	  
		 	8.3	 	[****]	  	 	18	  
		 	8.4	 	[****]	  	 	18	  
		 	8.5	 	Resolution of Differences	  	 	20	  
		 	8.6	 	[****]	  	 	20	  
		 	8.7	 	Invoicing	  	 	21	  
		 	8.8	 	Payment	  	 	21	  
		 	8.9	 	Taxes	  	 	22	  
			
	9.	 	RELATIONSHIP MANAGEMENT	  	 	22	  
		 	9.1	 	Relationship Committee	  	 	22	  
		 	9.2	 	Information Exchange	  	 	22	  
		 	9.3	 	Dispute Resolution	  	 	23	  
			
	10.	 	CHANGE CONTROL	  	 	25	  
		 	10.1	 	Changes	  	 	25	  
		 	10.2	 	Adoption of a Change	  	 	26	  
		 	10.3	 	Additional Products	  	 	26	  
			
	11.	 	INTELLECTUAL PROPERTY AND CONFIDENTIALITY	  	 	26	  
		 	11.1	 	Manufacturing Licence by the Buyer	  	 	26	  
		 	11.2	 	Foreground Intellectual Property	  	 	26	  
		 	11.3	 	No Implied Licences	  	 	27	  
		 	11.4	 	Confidentiality Undertaking	  	 	28	  
			
	12.	 	INDEMNITIES	  	 	28	  
		 	12.1	 	Buyer’s Indemnity Undertakings	  	 	28	  
		 	12.2	 	Sony DADC’s Indemnity Undertaking	  	 	29	  
		 	12.3	 	Control of Claims	  	 	29	  
			
	13.	 	LIMITATIONS OF LIABILITY	  	 	30	  
		 	13.1	 	Force Majeure	  	 	30	  
		 	13.2	 	Application of Limitations	  	 	31	  
		 	13.3	 	Excluded Losses	  	 	31	  
		 	13.4	 	Purchase Contract Limitations	  	 	31	  
		 	13.5	 	General Limitation	  	 	32	  
			
	14.	 	TERM AND TERMINATION	  	 	32	  
		 	14.1	 	Term	  	 	32	  
		 	14.2	 	Premature Termination	  	 	32	  
		 	14.3	 	Effect of Termination	  	 	33	  
		 	14.4	 	Continuance of Supply after Termination	  	 	34	  
		 	14.5	 	Suspension of Performance	  	 	34	  
		 	14.6	 	Alternate Supply	  	 	34	  

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

									
		
	 15.    AFFILIATES
	  	 	35	  
		 	15.2	 	Assignment	  	 	35	  
		 	15.3	 	Successors and Assigns	  	 	35	  
		 	15.4	 	No Waiver	  	 	36	  
		 	15.5	 	Variations	  	 	36	  
		 	15.6	 	Entire Agreement	  	 	36	  
		 	15.7	 	Relationship of the Parties	  	 	36	  
		 	15.8	 	Severability	  	 	36	  
		 	15.9	 	Costs and Expenses	  	 	36	  
		 	15.10	 	Third Party Rights	  	 	37	  
		 	15.11	 	Counterparts	  	 	37	  
		 	15.12	 	Notices	  	 	37	  
		 	15.13	 	Law and Proceedings	  	 	37	  
		
	EXHIBIT 1 TO SCHEDULE 2	  	 	41	  
		 	Specification	  	 	41	  
		
	 1.      SCOPE
	  	 	41	  
		
	 2.      GENERAL
	  	 	41	  
		
	 3.      PRODUCT SPECIFICATION
	  	 	41	  
				
		 	3.1	 	Reference Documents	  	 	42	  
		 	General Fluidic Specifications	  	 	42	  
		 	Other Specifications	  	 	43	  
		 	3.2	 	Masters	  	 	43	  
		
	 4.      QUALITY AGREEMENT TOPICS:
	  	 	46	  
		
	 •        QUALITY
	  	 	46	  
		
	 •        FEEDBACK
	  	 	46	  
		
	 •        PROCESS
	  	 	46	  
		
	 •        INVENTORY MANAGEMENT
	  	 	46	  
		
	 •        PACKAGING
	  	 	46	  
		
	 •        LABELING
	  	 	46	  
		
	 •        SHIPPING
	  	 	46	  
		
	 5.      QUALITY
	  	 	46	  
		
	 6.      CHANGE MANAGEMENT
	  	 	46	  

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

									
	 7.      DOCUMENTATION:
	  	 	47	  
		
	 8.      FEEDBACK
	  	 	47	  
		
	 9.      PROCESS
	  	 	48	  
		
	 10.    INVENTORY MANAGEMENT
	  	 	48	  
		
	 11.    PACKAGING
	  	 	48	  
		
	 12.    LABELING
	  	 	48	  
		
	 13.    SHIPPING
	  	 	49	  

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 THIS AGREEMENT is made on June 1 2011 

(“the Effective Date”) 
 BETWEEN 

 

	(1)	SONY DADC AUSTRIA AG a corporation organised and existing under the laws of Austria (registered no: FN34018b) having its seat or principal office at Sonystrasse 20 A-5081 Anif Austria (“Sony DADC”); and

  

	(2)	RAINDANCE TECHNOLOGIES, INC. a corporation organised and existing under the laws of the state of Delaware, USA having its principal place of business at 44 Hartwell Avenue, Lexington, MA 02421 USA (“the
Buyer”) 

 WHEREAS 
  

	(A)	The parties desire that the Products defined below which are from time to time required by the Buyer and its Affiliates be manufactured and supplied to it by Sony DADC 

 

	(B)	The parties further intend that from time to time they will co-operate in the development of additional products which may then be added to this Agreement upon terms to be agreed 

NOW IT IS AGREED that: 
  

	1.	PRELIMINARY 

  

	1.1	Definitions 

 In this Agreement including its recitals and schedules: 

 

			
	“Additional Product”	  	means a product which is added to this Agreement by the signature by the parties of a Product Addendum pursuant to clause 10.3;
		
	“Affiliate”	  	means:
		
		  	 (a)    in the case of Sony DADC—Sony DADC UK Limited of Southwater
Business Park Worthing Road West Sussex RH13 9YT UK; Sony DADC US Inc of 1800 N. Fruitridge Avenue Terre Haute IN47804 USA and Sony DADC Nuovo Laredo and any corporation, company, partnership, trust, association or other business entity which at the
relevant time is directly or indirectly controlled by Sony DADC;
  

(b)    in the case of the Buyer
-any

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

			
		  	 corporation, company, partnership, trust, association or other business entity which is directly or indirectly
controlled by the Buyer;
  
 for this purpose “control” means, in relation to
any such person or entity, the direct or indirect ownership of fifty per cent or more of the voting or other ownership interests in the relevant person or entity or the direct or indirect ownership of fifty per cent or more of the entitlement to
receive profit of the relevant person or entity or the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of the relevant person or entity (whether through ownership of securities or other
ownership interests or by contract or otherwise);

		
	“Certification”	  	means any certification, accreditation, license, approval, or standard or similar requirement which is required to be obtained, maintained or complied with by any applicable Laws or for compliance with the relevant provisions of
this Agreement;
		
	“Commencement Date”	  	means the later of the date specified as such in Schedule 1 or, the day after the successful completion of the four phases, including all deliverables stated therein and validation by Buyer of quantity, quality and effectiveness
of the completed work, under the Development and Cooperation Agreement, as executed by the parties on the 6th of March 2009 (“Development Agreement”). Completion of the Development Agreement may be in accordance with a written mutual
agreement that it has successfully completed;
		
	“Confidential Information”	  	 means:
  

(a)    any information of a proprietary or private nature concerning the finances, plans,
employees, customers, suppliers or other affairs of a party:
  

(b)    all know-how, expertise, technological information, data, formulae, designs, processes,
specifications, trade secrets, other knowledge and information of a technical nature or which is the subject of any Intellectual Property of a party;

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

			
		  	 (c)    the existence and terms of this Agreement;

		
	“Development and Co-operation Agreements”	  	means the agreements between the parties dated March 4, 2009 and October 18, 2010;
		
	“Dollar” or “$”	  	means United States Dollars, the lawful currency of the United States of America;
		
	“Effective Date”	  	means the date first written above;
		
	“Euro” and “€”	  	means Euro, the lawful currency of the Euro zone;
		
	“Intellectual Property”	  	means any Patents, rights to inventions, registered designs, copyright and related rights, database rights, design rights, topography rights, trade secrets, rights in unpatented know-how, rights of confidence and any other
intellectual property rights of any nature including all applications, all rights to apply for and renewals or extensions of such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future
in any part of the world;
		
	“Laws”	  	means any statute, law, subordinate legislation, by-law or ordinance of a governmental authority; any court order, judgment or decree binding upon the relevant party; any code, policy or standard of a regulatory authority
enforceable by law; any direction or requirement of any governmental, regulatory or other public authority required by law to be complied with by the relevant party, which in each case is at the relevant time in effect;
		
	“Normal Lead Time”	  	means the normal lead time for delivery of the relevant Product specified for it in Schedule 2;
		
	“Patents”	  	 means:
  

(a)    any patent, re-examination, reissue, renewal, extension, supplementary protection
certificate and term restoration, any confirmation patent or registration patent or patent of addition based on any such patent;
  

(b)    any pending application for a patent, including without limitation any continuation,
continuation-in-part, divisional, provisional and substitute application, and inventors’ certificate;
  

(c)    all foreign counterparts of any of the foregoing;
and

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

			
		  	 (d)    all priority applications of any of the foregoing;

		
	“Permitted Use”	  	means the purpose for which Products may be used as permitted by clause 5.3 which is specified in Schedule 2;
		
	“Product” or “Products”	  	means the product or products specified in Schedule 2 and any other product that may be specified in any Product Addendum, as the same are from time to time modified in accordance with this Agreement and including any new
version, development or successor of the same;
		
	“Product Addendum”	  	means any written agreement between the parties specifying a new or additional product which is to be a Product for the purposes of this Agreement;
		
	“Purchase Contract”	  	means a contract for the purchase of Products which results from the acceptance or deemed acceptance by Sony DADC of a Purchase Order;
		
	“Purchase Order”	  	means a purchase order for Products issued by Buyer pursuant to clause 4.1;
		
	“the Relationship Committee”	  	means the relationship committee in office at the relevant time pursuant to clause 9.1;
		
	“Safety Shock”	  	means any stock of Products to be maintained by Sony DADC pursuant to clause 5.6;
		
	“the Specification”	  	means the specification applicable to the relevant Product set out in Schedule 2 or in a revision of Schedule 2 agreed to in writing by the parties, or as the Specification is from time to time amended pursuant to clause
10;
		
	“Working Day”	  	means a day which is not a Saturday, Sunday or public holiday in either Austria or Boston, Massachusetts, USA; all other references herein to periods of days shall be interpreted as including all calendar days.

  

	1.2	Interpretation 

 In this Agreement: 

 

	 	1.2.1	clause headings shall be ignored in interpretation; 

  

	 	1.2.2	references to clauses, recitals and schedules are to the same in or to this Agreement unless otherwise stated; 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	1.2.3	each gender includes each other gender and the singular includes the plural and vice versa; 

  

	 	1.2.4	any reference to a term or concept in English law (including without limitation those for any action, remedy, dissolution, insolvency, method of judicial proceeding, document, statute, court official, governmental
authority or agency) shall in the context of any jurisdiction other than England be construed as a reference to the term or concept which most nearly corresponds to it in that jurisdiction; 

 

	 	1.2.5	references to “include”, “includes” or “including” shall be deemed to be followed by the words “without limitation” whether or not actually followed by such words

  

	2.	APPOINTMENT 

  

	2.1	Exclusive Appointment 

 Subject to clause 2.2, the Buyer hereby appoints Sony DADC the
exclusive supplier of each Product during the continuance of this Agreement in respect of that Product to the Buyer and its Affiliates and undertakes that neither it nor any of its Affiliates will obtain the supply of any Product from any person
other than Sony DADC nor will any of them satisfy any requirement for Product by its own manufacture or other self-supply 
  

	2.2	Permitted Third Party Supply 

 Notwithstanding clause 2.1: 

 

	 	2.2.1	the Buyer and its Affiliates may obtain supplies of Product from a third party in the event that Sony DADC has for any reason other than the default of the Buyer or any Affiliate of the Buyer committed a Persistent
Failure and notice under clause 2.2.2 has expired without the Persistent Failure being cured; for this purpose “Persistent Failure” means that, for a period of [****] consecutive months or in each of [****] months in any consecutive
period of [****] months, either Sony DADC has failed to deliver more than [****] per cent of Products due for delivery in each such month or more than [****] per cent of Products so delivered have suffered a material non-conformity with the
requirements of this Agreement; 

  

	 	2.2.2	the Buyer and its Affiliates shall not obtain any such third party supplies permitted by this clause 2.2 without first giving to Sony DADC at least thirty days’ notice of its intention to do so; if during that
thirty day period all Products due for delivery in that period have been delivered and have not suffered a material non-conformity with the requirements of this Agreement, the notice shall be of no effect and clause 2.2.3 shall not apply (but
without prejudice to its application on any other occasion to which it applies); 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	2.2.3	commencing upon the later of the occurrence of a Persistent Failure and expiry of notice of the Persistent Failure given pursuant to clause 2.2.2 without becoming of no effect, the appointment of Sony DADC under clause
2.1 will become non-exclusive and Buyer and its Affiliates shall have the right to purchase Product from a third party or manufacture Product for their own purposes. 

 

	2.3	Restriction on Other Relationships 

 Sony DADC agrees that, subject to clause 2.5,
neither it nor any of its Affiliates will: 
  

	 	2.3.1	supply any product which is the subject of this Agreement and has a Specification agreed between the parties and applied under this Agreement to any third party other than a third party designated by Buyer or with the
Buyer’s written consent, or grant rights to any third party to make, use or sell any such product other than as specifically set forth in clauses 2.2 and 14.6 of this Agreement; 

 

	 	2.3.2	develop, manufacture or sell on its own behalf or for a third party, any microfluidic polymer chip that incorporates or applies any Intellectual Property owned or controlled by the Buyer to any third party save a third
party designated by Buyer or with the Buyer’s prior written consent; 

  

	2.4	Restriction on MPC Development, Manufacture and Sale 

 Sony DADC agrees that, subject to
clauses 2.5 and 2.8, neither it nor any of its Affiliates will, during the period from the Effective Date until the date of termination of this Agreement plus an Extension Period as defined in clause 2.8, save with the prior written consent of the
Buyer, develop, manufacture or sell on its own behalf or for a third party which is engaged in developing, manufacturing, selling, or using (by itself or with another party) a microfluidic polymer chip [****] (a “Microdroplet Polymer
Chip”), a product that includes any combination of one or more of the following technologies: 
  

	 	(a)	[****]; 

  

	 	(b)	[****]; 

  

	 	(c)	[****]; 

  

	 	(d)	[****]. 

  

	2.5	Provisos 

 Clauses 2.3.2 and/or 2.4 shall not apply with respect to a third party which
is licensed by the Buyer under a Chip Manufacturing License, but such exclusion shall only apply for such periods as the Chip Manufacturing License is in effect. “Chip Manufacturing License” means a license entered into by Buyer licensing
the licensee to make or have made a Microdroplet Polymer Chip, provided that Buyer does not directly or indirectly 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 
provide Microdroplet Polymer Chips to such licensee. (For clarity, for any period during which Buyer does so provide Microdroplet Polymer Chips to such licensee, such license shall not be
considered a Chip Manufacturing License.) 
  

	2.6	Preferred Manufacturing Partner Status 

 The Buyer shall recommend Sony DADC to each of
its licensees as its preferred manufacturing partner for supply of Microdroplet Polymer Chips and similar items which are the subject of a license granted by the Buyer to any third party. Upon granting a license to a third party for any Microdroplet
Polymer Chip or similar item the Buyer shall refer the grantee to Sony DADC and (if the grantee consents to such disclosure) shall inform Sony DADC of the grant of the license. 

 

	2.7	IP Disclaimer 

 For clarity, nothing in clauses 2.3, 2.4, or 2.5 shall be interpreted as
a grant of any present or future licence by either party to the other to use in any way any Intellectual Property. 
  

	2.8	Revenue Threshold 

 Save that this clause 2.8 shall not apply if this Agreement is
terminated by the Buyer pursuant to clause 14.2 prior to the expiry of the first Initial Term under clause 14.1, the Extension Period referred to in clause 2.4 shall be [****] if the Total Aggregate Receipts (defined below) equals or exceeds [****]
if the Total Aggregate Receipts equals or exceeds [****] and is less than [****] if the Total Aggregate Receipts equals or exceeds [****] and is less than [****] if the Total Aggregate Receipts equals or exceeds [****] and is less than [****], and
[****] if the Total Aggregate Receipts is less than [****]. “Total Aggregate Receipts” means the total aggregate amounts received by Sony DADC or its Affiliates prior to the expiry of the first Initial Term under clause 14.1 pursuant to
any of the following contracts or events: 
  

	 	2.8.1	Purchase Contracts; 

  

	 	2.8.2	any contracts between the parties or any Affiliates of either of them created prior to the Effective Date for the purchase from Sony DADC by the Buyer of any products; 

 

	 	2.8.3	the Development and Co-operation Agreements; and 

  

	 	2.8.4	any revenues received by Sony DADC from third parties licensed by Buyer under a Chip Manufacturing License wherein such revenues are related to (a) microfluidic polymer chips that incorporate or apply any
Intellectual Property owned or controlled by the Buyer, or (b) products that include any combination of one or more of the technologies specified in clause 2.4 (a) through (d). 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	3.	FORECASTING 

  

	3.1	Information and Consultation 

 The Buyer shall use all reasonable endeavours to keep Sony
DADC fully informed as to its own and its Affiliates’ likely purchasing requirements for Products, with regard to volume and timing of purchases of each Product type; the parties shall consult together from time to time at the request of either
of them with regard to likely volumes of purchasing by the Buyer and its Affiliates under this Agreement and any appropriate implications for the planning of production and supply 

 

	3.2	Forecasts 

 Within [****] from the Commencement Date and thereafter at least [****]
before the end of each succeeding [****] the Buyer shall prepare and submit to Sony DADC a forecast of its expected purchasing requirements for each Product of the Buyer and its Affiliates for each of the [****] commencing on the [****]; all such
forecasts shall be prepared diligently and in good faith applying the best information available to the Buyer and its Affiliates at the time of issue and shall state for [****]: 

 

	 	3.2.1	the number of units of each Product expected to be the subject of a Purchase Order issued in that [****]; and 

  

	 	3.2.2	the number of units of each Product for which Purchase Orders have been or are expected to be issued for which the delivery date under clause [****] would [****]. 

 

	3.3	Status of Forecasts 

 The status of each forecast shall be as follows: 

 

	 	3.3.1	the Buyer undertakes that Purchase Orders with Normal Lead Times will have been issued before or will be issued during the [****] forecast by the Buyer and its Affiliates to Sony DADC which have a delivery date under
clause [****] which falls in [****] and are for the purchase of at least the number of units of each Product forecast for delivery in [****] pursuant to clause [****]; 

 

	 	3.3.2	the Buyer undertakes that Purchase Orders with Normal Lead Times will have been issued before or will be issued during the [****] forecast by the Buyer and its Affiliates to Sony DADC which have a delivery date under
clause [****] which falls in each [****] and are for the purchase of [****] of each Product forecast for delivery in [****] pursuant to clause [****]; 

  

	 	3.3.3	the Buyer undertakes that Purchase Orders with Normal Lead Times will have been issued before or will be issued during the [****] forecast by the Buyer and its Affiliates to Sony DADC which have a delivery date under
clause [****] which falls in [****] and are for the purchase of [****] of each Product forecast for delivery in that [****] pursuant to clause [****]; 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	3.3.4	if by [****] Sony DADC has not received Purchase Orders issued by the Buyer and its Affiliates for the number of units of each Product which the Buyer undertakes will be purchased with a delivery date under clause
[****] which falls in [****] as required by the [****], Sony DADC at the end of [****] may invoice the Buyer for and the Buyer shall [****] that would have been [****] had delivered the number of units of each Product so committed to be purchased
but which was not the subject of Purchase Orders issued with a delivery date under clause 6.3.3 which falls in [****] as so required; clauses [****] shall apply to such [****]. Upon receiving payment under [****], Sony DADC shall ship to Buyer so
much of the appropriate amount of Product as it then holds ready for supply and shall produce and ship the balance of that appropriate amount within the Normal Lead Time for its delivery; 

 

	 	3.3.5	subject to the foregoing sub-clauses, the forecasts, whilst prepared diligently and in good faith, shall not be binding commitments to purchase Products 

 

	4.	PURCHASE ORDERS 

  

	4.1	Issue 

 The Buyer and its Affiliates may from time to time after the Commencement Date
issue to Sony DADC Purchase Orders for Products and each Purchase Order shall be in writing (which includes electronic mail and electronic data input), shall specify the type and quantity of Product ordered, the desired delivery date, the delivery
shipment destination, any special labelling requirements and the Purchase Order number; any other contents of the Purchase Order shall be of no effect 
  

	4.2	Acceptance 

 Subject to clause 14.4, Sony DADC shall accept and fulfil all Purchase
Orders save to the extent that the number of units of Product the subject of Purchase Orders received and for which the delivery date applicable under clause 6.3.3 falls in the same month exceeds the quantities of Products for which delivery was
forecast pursuant to clause 3.2.2 (whether in respect of all Products of the same type or of all Products in total, regardless of type) 
  

	4.3	Confirmation 

 Within three Working Days from receipt of a Purchase Order Sony DADC shall
issue to the Buyer (or its Affiliate which issued the Purchase Order) its confirmation, which shall be in writing (which includes electronic mail and electronic data input) and shall be acceptance of the Purchase Order for delivery on the delivery
date pursuant to clause 6.3 unless (being entitled under the preceding clause 4.2 to do so) Sony DADC elects to reject the Purchase Order; if within the said three Working Days Sony DADC (being entitled to do so) has not by written notice to the
Buyer rejected the Purchase Order it shall be deemed to have accepted it. No other contents of any acceptance, other than an indication of acceptance or rejection, shall be of effect in any confirmation or invoice issued by Sony DADC 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	4.4	Minimum Shipment Quantities 

 Each Purchase Order shall be for the minimum shipment
quantity of the relevant type of Product the subject of the Purchase Order specified in Schedule 2; for this purpose Purchase Orders for the same type of Product to be shipped on the same date to the same destination shall be treated as if they were
a single Purchase Order 
  

	4.5	Purchase Contracts 

 Upon acceptance or deemed acceptance by Sony DADC of a Purchase
Order, a Purchase Contract shall thereupon exist upon the terms of this Agreement and subject thereto upon the details of that Purchase Order specified pursuant to clause 4.1; each such Purchase Contract shall be a separate contract from this
Agreement and from each other Purchase Contract 
  

	5.	MANUFACTURE OF THE PRODUCTS 

  

	5.1	Specification 

 Sony DADC shall manufacture and supply Products which are the subject of
Purchase Contracts in accordance with the applicable Specification and otherwise in accordance with this Agreement 
  

	5.2	Compliance with Laws 

  

	 	5.2.1	Sony DADC shall comply with all applicable Laws in relation to the manufacture and delivery of Products, including providing lists of all parts and such documentation as is required for delivery under clause 6.1;

  

	 	5.2.2	the Buyer shall comply with all applicable Laws in relation to any Product after its delivery pursuant to clause 6.1, including any use, supply to third parties or other dealing with it; 

 

	 	5.2.3	without limiting the foregoing, Sony DADC shall obtain and maintain all Certifications that are required by Laws to be obtained in respect of the manufacture and delivery of Products for their Permitted Use and the
Buyer shall be responsible for obtaining and maintaining all Certifications required by Laws relating to any use, re-supply or other dealing with any Product after its delivery pursuant to clause 6.1; 

 

	 	5.2.4	 Sony DADC shall cause each Product upon its delivery to comply with the country requirements stated in the Specification applicable to it; if
different requirements are stated in the Specification for different countries, Sony DADC shall cause the Products supplied pursuant to a Purchase Contract to comply with the country requirements referred to in the Specification which are specified
in the relevant Purchase Order; Sony DADC shall have no responsibility for complying in respect of any Product with any country requirements unless the country 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	
requirement is both referred to in the applicable Specification or otherwise agreed upon in writing by the parties and the appropriate part number identifying such country requirement is
referenced in the applicable Purchase Order 

  

	5.3	Permitted Use 

 Without limiting the provisions of clause 5.2, Sony DADC’s
manufacture and supply of Product pursuant to this Agreement is subject to compliance by the Buyer with the following: 
  

	 	5.3.1	the Buyer shall not use any Product for any purpose other than its Permitted Use; 

  

	 	5.3.2	the Buyer shall not re-supply to any third party any Product except for its Permitted Use and shall include as a term of its contract for such re-supply (or use other appropriate means consistent with industry practices
which effectively impose such obligation) an undertaking by the purchaser of the Product that it will comply with the same obligations as the Buyer undertakes under this clause 5.3; 

 

	 	5.3.3	the Buyer shall not modify any Product in any way but shall use and re-supply in the same form in which it is delivered to it, subject to addition of labels, bar codes and other packaging; 

 

	 	5.3.4	Expansion of Permitted Uses. Sony DADC shall not unreasonably withhold its consent to any expansion of the definition of Permitted Use. If the Buyer requests expansion of the definition of Permitted Use into an
area that requires compliance with material additional regulatory requirements, including current good manufacturing practices in a country, Sony DADC shall respond by providing a written proposal to Buyer of the reasonable costs of any changes to
the processes for production and/or facility changes required to meet such material additional regulatory requirements, and the effect of such changes, if any, including on price and delivery lead time. The parties shall meet to discuss the proposed
changes, and will seek in good faith to agree on the best means of implementing the changes, making a fair allocation of costs and a fair adjustment to the price and delivery lead times, and any other changes to this Agreement necessary for Buyer
and its customers to gain or maintain approval in the regulated indication without adverse effect upon Sony DADC. If the parties agree to expand the definition of the Permitted Use, such agreement and any resulting changes agreed upon by the parties
will be documented in a written amendment to this Agreement, which will include an obligation on the part of Sony DADC to cooperate in good faith, including by providing at the expense of the Buyer and (where appropriate) under conditions of
confidentiality any information, as reasonably requested by Buyer, which is required in order to obtain and maintain regulatory approval in the area of the expanded Permitted Use 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	5.4	Packaging 

 Sony DADC shall deliver Products with the packaging required by the
Specification and consistent with standard industry practices 
  

	5.5	Manufacturing Undertakings 

 Sony DADC undertakes with the Buyer that, in place of any
other warranty or condition as to quality, condition, description, compliance with sample, fitness for purpose or otherwise and whether express or implied, statutory or otherwise (all of which are hereby expressly excluded from this Agreement to the
fullest extent permitted by Law), ail Products supplied by Sony DADC pursuant to this Agreement: 
  

	 	5.5.1	will conform in all material respects to the applicable Specification; 

  

	 	5.5.2	will be free from any defect in materials or workmanship; 

  

	 	5.5.3	will have been manufactured in compliance with all applicable Laws 

  

	5.6	Safety Stock 

 If any Safety Stock requirement is specified for a Product in Schedule 2
or in a Product Addendum, the following shall apply: 
  

	 	5.6.1	Sony DADC shall maintain the lower of the following quantity of Safety Stock: 

  

	 	(a)	the quantity specified for that Product in Schedule 2 or the Product Addendum, as applicable; 

  

	 	(b)	such quantity of Safety Stock as the Buyer may designate from time to time in writing to Supplier; 

  

	 	5.6.2	if Sony DADC uses Safety Stock to fulfil a Purchase Contract, Sony DADC shall replenish the Safety Stock promptly; 

  

	 	5.6.3	Sony DADC shall ship Safety Stock to the Buyer on a first in, first out basis; 

  

	 	5.6.4	the Safety Stock shall be held by Sony DADC at its own cost, expense and risk and without storage or other charge to the Buyer; 

  

	 	5.6.5	if Sony DADC so requests to the Buyer in writing, the Buyer shall issue a Purchase Order for all the following Products (and if it fails to do so within seven days from such request it shall be deemed that it had done
so on the expiry of that period): 

  

	 	(a)	all Products held in Safety Stock for more than one hundred and eighty days (assessed on a first in, first out basis) that are specified in Sony DADC’s request; 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	(b)	if pursuant to this Agreement there is any change to the Specification of a Product held in Safety Stock or if any Product so held is rendered obsolete or the sale thereof is discontinued by the Buyer, all items in the
Safety Stock so affected which are specified in Sony DADC’s request; 

  

	 	5.6.6	upon termination of this Agreement for any reason and in any manner it shall be deemed that the Buyer has issued a Purchase Order for all the Safety Stock then held by Sony DADC; Sony DADC may immediately invoice the
Buyer for all such Safety Stock and the Buyer shall pay such invoice within seven days of receipt, following payment of which Sony DADC shall deliver the Safety Stock to the Buyer in accordance with clause 6.1 

 

	6.	DELIVERY 

  

	6.1	Delivery 

 Delivery of Products shall be effected EXW (ex-works) Sony DADC’s
manufacturing facility INCOTERMS 2000, which shall apply subject to the express provisions of this clause 6; delivery may be effected in instalments as long as Sony DADC complies with its obligations under clause 6.3.2 in respect of the relevant
Purchase Order 
  

	6.2	Shipment 

 Sony DADC shall deliver Products in accordance with clause 6.1 for shipment as
follows: 
  

	 	6.2.1	delivery shall be for shipment to the shipment destination stated for the relevant Product in the relevant Purchase Order; 

  

	 	6.2.2	each shipment shall be accompanied by a packing slip which shall include the Purchase Order number, Sony DADC’s part number and the quantity of Products contained in the shipment; 

 

	 	6.2.3	delivery shall be effected to a carrier designated by the Buyer; the Buyer shall consult with Sony DADC upon the choice of carrier and shall take all reasonable account of Sony DADC’s recommendations in relation to
the choice of carrier and otherwise concerning freight to the request destination 

  

	6.3	Delivery Date 

 Subject to clause 14.4, the following shall apply with regard to the date
for delivery of Products: 
  

	 	6.3.1	unless otherwise expressly agreed in writing, no deliveries shall be made more than seven days in advance of the Buyers specified delivery date: the Buyer may invoice Sony DADC for and, if invoiced, Sony DADC will pay
to the Buyer reasonable storage charges for Product delivered more than seven days in advance of the specified delivery date; 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	6.3.2	Sony DADC shall diligently seek to deliver Products on the delivery date applicable under this clause 6.3 but shall not be liable for any delay in delivery unless such delay is due to any negligence or wilfulness on the
part of Sony DADC or any of its Affiliates or any of their respective employees or agents; 

  

	 	6.3.3	the delivery date applicable to any Products which are the subject of a Purchase Order issued within a binding purchase commitment in the forecast for the current month submitted by the Buyer pursuant to clause 3.2
shall be the later of the Normal Lead Time for such Products and the delivery date specified in the Purchase Order; 

  

	 	6.3.4	the delivery date applicable to Products which are the subject of a Purchase Order which is issued in excess of the binding purchase commitment in the forecast for the current month submitted by the Buyer pursuant to
clause 3.2 shall be as follows: 

  

	 	(a)	in the case of Purchase Orders which are for a volume within the said binding purchase forecast plus available safety stock or do not exceed a monthly maximum volume for all types of Product as specified in Schedule 2
as the “Monthly Maximum Volume” -the later of the Normal Lead Time for such Products and the delivery date specified in the Purchase Order; 

  

	 	(b)	in the case of Purchase Orders which are for a volume both in excess of the said binding purchase forecast plus available safety stock and in excess of the Monthly Maximum Volume—the latest of the delivery date
requested in the relevant Purchase Order, the Normal Lead Time for such Products and three months from the date of the Purchase Order 

  

	6.4	Inspection and Acceptance 

 The following shall apply with regard to non-compliance of
Products with the requirements of this Agreement: 
  

	 	6.4.1	each shipment shall be accompanied by a certificate of conformance that the shipment conforms to all relevant Specifications; 

  

	 	6.4.2	immediately upon receipt of any Products, the Buyer shall inspect the same to check for any incorrect quantity and shall notify Sony DADC in writing within four Working Days of receipt of the Products stating any
incorrect quantity; except for any such incorrect quantity which is so notified within that period, the Products delivered shall be deemed to have been delivered in the correct quantity; 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	6.4.3	no later than thirty days from delivery of any Products pursuant to clause 6.1 the Buyer shall notify Sony DADC in writing of any respect in which the Products delivered do not comply with this Agreement in a respect
which is reasonably apparent on physical inspection; except for any non-compliance which is so notified within that period the Products delivered shall be deemed to comply with this Agreement in all respects as to any defect that is reasonably
apparent upon physical inspection; 

  

	 	6.4.4	If the Buyer finds any non-compliance and notifies it to Sony DADC in accordance with this clause 6.4 within the relevant period thereby allowed, the parties shall consult together as to the appropriate action to be
taken; 

  

	 	6.4.5	if the parties fail to agree upon such action the Buyer may return the Products affected by the non-compliance to Sony DADC carriage paid and Sony DADC shall supply free of charge replacement Products as if such
replacement Products had been ordered under a Purchase Order issued on the date that the Buyer notifies Sony DADC of the return of the non-conforming Products. Upon receipt of the returned Products, Sony DADC shall inspect the same in good faith and
should Sony DADC determine in good faith the non-compliance originated at or was caused by Sony DADC then Sony DADC shall reimburse the Buyer for the cost of shipment and insurance incurred in returning the Products to Sony 

 

	7.	RISK AND TITLE 

  

	7.1	Risk 

 Risk in Products delivered shall pass upon delivery pursuant to clause 6.1 in
accordance with EXW (ex-works) INCOTERMS 2000 
  

	7.2	Title 

  

	 	7.2.1	If at the time of such delivery Sony DADC has received full payment of the price for the Products or the price is fully covered by a letter of credit or guarantee issued and confirmed by an institution approved by Sony
DADC and in form and terms approved by it, then title to and ownership of the Products shall pass to the Buyer upon delivery pursuant to clause 6.1 

  

	 	7.2.2	If at the time of such delivery such price has not been so paid and is not so fully covered then title to and ownership of the Products shall not pass until the earlier of: 

 

	 	(a)	the time at which Sony DADC receives, in cash or cleared funds, payment in full of the purchase price of those Products and of the purchase price for any other goods or services supplied by Sony DADC to the Buyer
pursuant to this Agreement which at the date when payment for the Products falls due is overdue for payment and is not the subject of a good faith dispute (as referred to in clause 8.8); and 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	(b)	the time at which the Products are delivered by the Buyer to a customer pursuant to a sale in good faith in the ordinary course of business 

 

	 	7.2.3	Until such time as property and ownership in the Products passes to the Buyer pursuant to this clause 7.2, the Buyer shall hold the Products as fiduciary agent and bailee on behalf of Sony DADC and at Sony DADC’s
written request with respect to an overdue payment which is not disputed in good faith (as provided in clause 8.8) shall deliver up the same to Sony DADC or to a person designated in writing by Sony DADC 

 

	8.	PRICE 

  

	8.1	Payment Obligation 

 The Buyer shall pay, in accordance with clause 8.8, the price
applicable to the relevant Product which is in force pursuant to this clause 8 at the date of issue of the relevant Purchase Order or (if the relevant Purchase Order specified a desired delivery date which is later than the Normal Lead Time) at the
price in force at the date delivery under that Purchase Order falls due under clause 6.3 
  

	8.2	Initial Price 

 The initial prices for the Products are set out in Schedule 2 

 

	8.3	[****] 

 The following shall apply in respect of [****] between [****] and [****]: 

 

	 	8.3.1	if the [****] with [****], as determined by [****] agreed between the parties (or in the event of failure to agree selected by [****] from [****] proposed by [****]), is more than [****] then at the request of [****]
the parties shall consult together upon the action to be taken to alleviate the effect upon [****] and if [****] so requests [****] shall submit to [****] a plan to move production of the [****] (as now specified in [****] or as may be modified
pursuant to this Agreement, hereafter referred to simply as the [****]) to a location within a [****]; 

  

	 	8.3.2	on each occasion that any product other than the [****] is added to this Agreement by a Product Addendum, they shall agree [****] of the same to reflect [****] and shall record the [****] in the relevant Product
Addendum (or other document by which the new item becomes subject to this Agreement); 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	8.4	[****] 

 All prices payable by [****] for the Product shall be adjusted annually as
follows: 
  

	 	8.4.1	in this clause 8.4: 

 [****] means (in the case of the first [****]) the [****] specified as
the [****] in [****] and (in the case of subsequent [****]) each [****] of [****]; 
 [****] means the result of dividing [****] the [****]
of the [****]; 
 [****] means the [****] for the [****] of the [****]; 

[****] means the [****] for the [****] of the [****]; 

[****] means respectively the [****] by [****] as has been substituted at the [****] pursuant to clause [****]; or, if [****] of [****] of the
[****] is [****],[****] for the [****] the [****] published by the [****]. 
 [****] means a figure of the [****] by [****] the [****], as
the case may be; 
 [****] means the [****] by which the [****] the [****]; 

 

	 	8.4.2	following the end of each [****] each [****] shall be compared with the [****], there shall be [****] the [****] and the [****] and the [****] for each [****] at the [****] at the end of that [****] shall be [****] (as
the case may be) by [****] the [****]; 

  

	 	8.4.3	as soon as practicable after the [****] for the relevant [****] shall [****] the [****] and [****]; 

  

	 	8.4.4	the [****] pursuant to [****] shall apply to all [****] for which the [****] was issued after the end of the [****] to which the [****] and to all [****] which result from a [****] issued earlier with [****] requested
by the [****] which is later than the [****]; 

  

	 	8.4.5	if at any time an [****] to the [****] which has [****] and in that event or if there is any [****] or the [****] of its [****] such changes shall be made for the purposes of this clause [****] as will render the [****]
for the purposes of [****]. 

  

	8.5	Resolution of Differences 

 If any difference of opinion arises in respect of adjustment
of the prices pursuant to the foregoing provisions of this clause 8 only, the same shall be submitted to an independent accountant agreed between the parties or in default of agreement appointed on the application of either of the parties by
President for the time being of the Institute of Chartered Accountants in England and Wales who shall act as expert not arbitrator and whose decision shall be final, binding and conclusive and his fees shall be borne by the parties in such
proportions as he shall decide 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	8.6	[****] 

 [****] for [****] under this Agreement shall be [****] during the [****]
specified in [****] in each [****] commencing in the [****] specified in [****] and the following shall apply in this respect. 
  

	 	8.6.1	during the [****] in each [****] the [****] under this Agreement taking into account all relevant circumstances, including [****] in [****], the [****] were the [****] during the [****], and the [****] at which [****]
the [****] to its [****]; 

  

	 	8.6.2	the [****] in [****] and [****] to [****] to an [****] to the [****] which is [****] to [****] in light of all relevant circumstances [****] that [****] the [****] for the [****] of the [****] and [****] into [****] the
[****] of [****], to be [****] on the [****], that [****] a [****] to [****] and a [****] to [****]; 

  

	 	8.6.3	if the [****] to [****] to any [****] to the [****] by the [****] of the [****] in the [****], the [****] then [****] to [****] and [****] the [****] the [****] to [****] in [****] to the [****] and [****]; if [****]
that [****] an [****] to the [****], such [****] as [****] and [****] in [****] and from the [****] of the [****] the [****] in [****] by the [****] and [****] to be [****] to [****] the [****] of this [****] to this [****]; 

 

	 	8.6.4	[****] the [****] to [****] any [****] to the [****] by [****] of the [****] to in the [****], the [****] then [****] in [****] to [****] the [****] this [****] this [****]; 

 

	 	8.6.5	any [****] or [****] to this [****] the [****] in [****] with [****] from the [****] of the [****] the [****] of [****] to the [****] of this [****]. 

 

	8.7	Invoicing 

 Sony DADC shall invoice the Buyer immediately upon delivery of the relevant
Product pursuant to clause 6.1; the Buyer shall provide Sony DADC with the communication details for submission of invoices and Sony DADC shall submit invoices, whether electronically or in hard copy, to the address so notified by the Buyer. All
invoices shall state the Purchase Order number, the number and type of Products delivered and the amount payable 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	8.8	Payment 

 Except for amounts invoiced which are disputed in good faith, the Buyer shall
pay Sony DADC in all invoices without deduction or set-off net forty-five days from the date of receipt of the invoice by payment in cleared funds to a bank account nominated by Sony DADC. An amount shall not be disputed in good faith unless: 

 

	 	8.8.1	within fifteen Working Days following the receipt of such invoice, the Buyer notifies Sony DADC specifying in reasonable detail a substantial reason for the dispute; save for the reason stated in such notice given
within that period the invoice shall be conclusively deemed for the purposes of payment to be properly payable and the Buyer shall pay the same as provided by the foregoing provisions of this clause 8.8; 

 

	 	8.8.2	the Buyer shall pay to Sony DADC as aforesaid the entire amount of the invoice save for the amount which is disputed by the notice given pursuant to the preceding clause 8.8.1; 

 

	 	8.8.3	a reason shall not be substantial if it relates merely to the omission of a reference, order number or other detail but is substantially identifiable and correct; 

 

	 	8.8.4	each party shall use its reasonable endeavours in good faith to resolve the dispute as soon as possible 

  

	8.9	Taxes 

 All prices are exclusive of value added tax and sales tax and any similar tax,
all of which the Buyer shall pay in addition to the price subject to receipt of an appropriate invoice for the same 
  

	9.	RELATIONSHIP MANAGEMENT 

  

	9.1	Relationship Committee 

 The parties shall establish and maintain a relationship
committee (“the Relationship Committee”) and the following shall apply: 
  

	 	9.1.1	the Relationship Committee shall comprise four individuals in total. Each of the parties shall appoint, and may from time to time remove, and reappoint two members of the Relationship Committee; 

 

	 	9.1.2	the role of the Relationship Committee shall be to manage the relationship between the parties in all respects, to oversee the conduct of this Agreement, to resolve differences and difficulties which may arise in the
course of the Agreement, to review each party’s performance under this Agreement, to discuss any issues that may have arisen regarding Products or Product ordering, consumption, technical or quality matters, inventory, reasonable means of cost
reduction, and the general co-operation between the parties and to seek ways to improve the operation of the Agreement to mutual benefit; 

  

	 	9.1.3	the Relationship Committee shall meet on a quarterly basis, in person or via teleconference, and otherwise as considered appropriate; 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	9.1.4	each party shall appoint a leader of its relationship team whose responsibility shall be to initiate and maintain contact with the relationship team leader of the other party; 

 

	 	9.1.5	the Relationship Committee shall not have power to vary this Agreement or to bind either of the parties to any legal commitment 

  

	9.2	Information Exchange 

 Each of the parties shall keep the other informed about matters
within its knowledge that are likely to have a material effect upon the operation of this Agreement and in particular Sony DADC shall report to the Buyer on a quarterly basis the shipments and delivery lead times for Products delivered during the
quarter under report. In the event a material quality issue is identified by either Sony DADC or by the Buyer that is likely to have a material adverse effect on the delivery of products by Sony DADC, the parties shall then consult together as a
matter of urgency to agree to the validity of the problem and agree to a solution to the problem, both in respect of maintaining deliveries and in respect of resolving the production problem. If Buyer requests the right to view the process to better
understand the problem, Sony DADC shall permit, and cause its Affiliates to permit, Buyer to inspect the facilities and records relevant to the production of Product for the purposes of reaching mutual agreement on corrective action. Buyer shall
provide Sony DADC with reasonable advance notice to any such inspection, which may be repeated if required to address the problem. Each inspection shall be conducted in compliance with such reasonable procedures concerning security and
confidentiality as Sony DADC specifies and shall be conducted with a view to causing the least practical disruption to the business of Sony DADC. 
  

	9.3	Dispute Resolution 

 The parties each recognise that it is important to establish a close
working relationship, to avoid disputes arising and to ensure that any disputes which do arise are speedily resolved without interruption to the operation of this Agreement or the commercial relationship between them. Accordingly, if any dispute
arises under or in relation to this Agreement or any Purchase Contract; 
  

	 	9.3.1	the parties shall seek in good faith to resolve the same as soon as practicable so as not to interfere with or damage the working relationship between them in other matters; 

 

	 	9.3.2	the existence of any dispute shall not be treated as a reason for withholding purchase orders, supplies, payment or other performance of this Agreement or any Purchase Contract other than payment of amounts which are
disputed in good faith as provided in clause 8.8; 

  

	 	9.3.3	 if either party considers that the other is in breach of its obligations under this Agreement or any Purchase Contract and wishes to take action in
respect of such breach it shall notify the other party of the breach with relevant information in its 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	
possession concerning the breach and a summary of its proposals in respect of it. The parties shall then consult in good faith with regard to actions to be taken to cure the breach and prevent a
repetition and if the party in breach puts forward reasonable proposals in that respect (taking into account any previous similar breach) the party complaining of the breach shall allow a reasonable period (being not less than fifteen days nor more
than forty-five days) for the same to be implemented; 

  

	 	9.3.4	any dispute or difference shall be referred in the first instance to the Relationship Committee which shall diligently seek to resolve the same. If the Relationship Committee fails to resolve the same, the relationship
team members of each party shall prepare a written memorandum summarizing the matter in dispute, their views upon it and their understanding of the other party’s views upon it and the parties shall then exchange their respective memoranda and
the Relationship Committee shall then meet again to discuss the matter. If at that meeting they fail to resolve the matter the memoranda prepared by the parties and discussed at the meeting, together with minutes of the meeting, shall be submitted
to a senior executive officer (being executive vice president or Chief Operating Officer or more senior) of the respective parties, who shall meet as soon as practicable and seek to resolve the matter; 

 

	 	9.3.5	subject to clause 9.3.6, a party shall not: 

  

	 	(a)	serve any notice under clause 14.2 (whether notice to remedy or notice of termination of this Agreement) by reason of a breach by the other party of its obligations under this Agreement or any Purchase Contract (but
shall remain entitled to any compensation available to it in law) and any such notice purportedly given in respect of that breach shall be of no effect; nor 

  

	 	(b)	commence any legal proceedings in respect of the breach or matter in dispute 

 unless in either case it has
allowed any implementation period required by clause 9.3.3 to expire and the remedy has been unsuccessful, has caused its members of the Relationship Committee to be reasonably available to meet those of the other party, has submitted to the other
party the memorandum required by clause 9.3.4 and has made a senior executive officer reasonably available to meet pursuant to clause 9.3.4; 
  

	 	9.3.6	subject to any binding agreement resolving a dispute and subject to the foregoing, nothing in this clause 9.3 shall prevent or restrict any party exercising its rights and remedies in law and notwithstanding the
foregoing either party may apply to court for injunctive relief in respect of any breach or alleged breach of clauses 11 or 12 or for a court order for payment of any invoice that is overdue for payment 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	10.	CHANGE CONTROL 

  

	10.1	Changes 

 The following shall apply in respect of changes to the Specification: 

 

	 	10.1.1	Change Proposals by the Buyer: The Buyer may at any time or times propose to Sony DADC in writing a change to the Specification of any Product and any such change notice shall specify in reasonable detail
the change required and the reasons and objectives for it; within thirty days from receiving from the Buyer any such change notice, Sony DADC shall respond within thirty (30) days from receipt of any such change notice stating whether or not
the change is acceptable and if acceptable, the changes which Sony DADC proposes to the relevant price, delivery lead-time and any other consequences of adopting the proposed change. Buyer shall reply in writing to any such change notice specifying
whether or not it is acceptable; Buyer will assume the costs for additional samples produced for the evaluation of the change proposed by Buyer. 

  

	 	10.1.2	Change Proposal by Sony DADC: Sony DADC may at any time or times propose to the Buyer a change in the Specification of any Product and any such change notice shall be in writing and shall specify in
reasonable detail the change proposed, the reasons and objectives for it and the effect which Sony DADC proposes for the price, delivery lead-time and any other consequences of adopting the proposed change; within thirty days from receipt of any
such change notice the Buyer shall reply in writing to any such change notice stating whether or not it is acceptable; Sony DADC will assume the costs for additional samples produced for the evaluation of the change proposed by Sony DADC.

  

	 	10.1.3	Consultation: If either party serves a change notice pursuant to this clause 10.1 and the same is not accepted by the other party, the parties shall consult together with regard to the proposed change and
seek in good faith to agree upon the best means of meeting the reasons and objectives for the proposed change and of any fair adjustment to the price, delivery lead-times and other consequences of the change for either party; upon reaching agreement
upon the change and its said implications the parties shall sign a memorandum confirming such agreement and specifying the changes agreed to the Specification and to the terms of supply 

 

	10.2	Adoption of a Change 

 Any change proposed shall be adopted only when it has been agreed
between the parties, either by written notice given by the recipient of the proposal pursuant to clauses 10.1.2 or 10.1.3 or by signature of a memorandum following consultation pursuant to clause 10.1.4; until such agreement is reached the change
shall not be implemented unless it is required by applicable Law, in which case after good faith discussion it shall be implemented as so required and the initial price and delivery lead time shall be amended, as required by Sony DADC in order to
comply with the applicable Law requiring its implementation, to reflect increased manufacturing cost and time, if any 
  

	10.3	Additional Products 

 The parties intend that additional products similar in concept to
the Products may be developed and added to this Agreement by signature of a Product Addendum (each an “Additional Product”), but such future development and Products are uncertain and not guaranteed by either party 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	11.	INTELLECTUAL PROPERTY AND CONFIDENTIALITY 

  

	11.1	Manufacturing Licence by the Buyer 

 The Buyer hereby grants to Sony DADC during the
continuance of this Agreement a non-exclusive licence under all Intellectual Property now or from time to time held by the Buyer (whether owned by it or held under licence permitting it to grant the sub-licence granted by it in this clause 11.1),
solely for the purposes of Sony DADC performing this Agreement and Purchase Contracts; Sony DADC may sub-licence such intellectual property to its Affiliates (and, only with Buyer’s prior written approval and not otherwise, to sub-contractors
which are not Affiliates of Sony DADC) solely to enable them to produce Products for supply to the Buyer under this Agreement. The license granted under this clause 11.1 shall terminate immediately upon the expiration or termination of this
Agreement and all Purchase Contracts 
  

	11.2	Foreground intellectual Property 

 Intellectual Property generated during the course and
in pursuance of this Agreement shall be owned as follows: 
  

	 	11.2.1	all Intellectual Property generated by either of the parties or by the parties jointly in respect of the means or manner of production of Products (including drawings, DVD and CD and other equipment, software, data,
know-how and processes used by Sony DADC in performing the Agreement) shall be owned by Sony DADC absolutely; Sony DADC shall not enforce any Patents against the Buyer or a third party in respect of any manufacture of Products by the Buyer or by a
third party for the Buyer as permitted (and for so long only as such manufacture is permitted) by clause 2.2 or clause 14.6, nor in respect of the sale of any Products manufactured by the Buyer or by a third party for the Buyer while so permitted,
nor in respect of the use of any Products manufactured by the Buyer or by a third party for the Buyer as so permitted; 

  

	 	11.2.2	 subject to the preceding clause 11.2.1, all Intellectual Property generated by either Party or any of their Affiliates under this Agreement that is an
improvement to or extension of the Intellectual Property owned by Buyer and/or licensed by Buyer under clause 11.1 shall be owned by Buyer regardless of which party invented such Intellectual Property, and Sony DADC agrees to and hereby does assign
to Buyer such Intellectual Property generated by Sony DADC and its Affiliates and agrees to cooperate fully at the expense of the Buyer in effectuating such assignment. All Intellectual Property generated under this Agreement that is an improvement
to or extension of the Intellectual Property owned by Sony DADC shall be owned by Sony DADC regardless of which party invented such Intellectual Property, and Buyer agrees to and hereby does assign to Sony DADC such Intellectual Property generated
by Buyer and agrees to cooperate fully at the 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	
expense of Sony DADC in effectuating such assignment, provided that, for the sake of clarity any Intellectual Property related to the design or use of the Product or the functionality of
Microdroplets (as defined in clause 2.4(a)) within the Product will be considered to be an improvement to Intellectual Property owned by Buyer and not an improvement to Intellectual Property owned by Sony DADC, and any Intellectual Property related
to the means or manner of production of the Product will be considered to be an improvement to Intellectual Property owned by Sony DADC and not an improvement to Intellectual Property owned by the Buyer 

 

	11.3	No Implied Licences 

 Except as expressly stated in this Agreement, nothing in this
Agreement constitutes any change in ownership of any Intellectual Property or the grant of any licence by either party to the other to use in any way any Intellectual Property of the other and in particular; 

 

	 	11.3.1	Sony DADC shall not use any Intellectual Property of the Buyer except as permitted by clause 11.1; 

  

	 	11.3.2	the Buyer shall not use any Intellectual Property of Sony DADC except as set forth in clauses 2.2 and 14.6; and 

  

	 	11.3.3	for clarity, the parties acknowledge and agree that any Intellectual Property generated in the course and pursuant to the Development Agreement is not Intellectual Property generated during the course of this Agreement
but instead the terms of the prior agreement will continue to cover 

  

	11.4	Confidentiality Undertaking 

 The provisions of the Confidentiality and Non-Disclosure
Agreement between the parties dated December 10, 2009 (the “NDA”) shall have effect as if set out in this Agreement and the parties shall observe their respective obligations there under accordingly, subject to the following: 

 

	 	11.4.1	In clause 2 of the NDA, the Term shall be the period during which this Agreement continues in effect and not as stated in that clause; 

 

	 	11.4.2	In clause 5 of the NDA, Non-Technical as well as Technical information shall be deemed to be checked; 

  

	 	11.4.3	The words “For a period of [****] from the Effective Date” shall be deemed to be deleted from the second sentence of clause 8 of the NDA and replaced by the words “During the continuance of the Supply
Agreement between the parties and for [****] after its expiration or termination”; 

  

	 	11.4.4	Clause 14 of the NDA shall have effect subject to clause 11 of this Agreement. 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	11.4.5	Buyer shall have such additional rights of disclosure and use of Non-Technical information, Technical Information and other confidential information of Sony DADC and its Affiliates as are expressly set forth in clause
14.6. 

  

	12.	INDEMNITIES 

  

	12.1	Buyer’s Indemnity Undertakings 

 The Buyer shall indemnify Sony DADC, its Affiliates
and their respective officers, employees and representatives (“Sony Indemnified Party”) against all costs, claims, losses, damages, expenses and liability to the extent arising from or in connection with: 

 

	 	12.1.1	any claim by any third party that any part of the design or specification of the relevant Product specifically provided by the Buyer infringes any rights of any person relating to Intellectual Property or otherwise or
does not comply with any applicable Laws; 

  

	 	12.1.2	any claim by any third party that the design or specification of any Product specifically provided by the Buyer directly or indirectly caused any; 

 

	 	(a)	personal injury; 

  

	 	(b)	death; or 

  

	 	(c)	other damage or injury 

  

	12.2	Sony DADC’s Indemnity Undertaking 

 Sony DADC shall indemnify the Buyer, its
Affiliates and their respective officers, employees and representatives (“Buyer Indemnified Party”) against all costs, claims, losses, damages, expenses and liability arising from or in connection with any claim by any third party that;

  

	 	12.2.1	the manufacture or workmanship of any Product, or the packaging of the Product supplied by Sony DADC, directly or indirectly caused any: 

 

	 	(a)	personal injury; 

  

	 	(b)	death; or 

  

	 	(c)	other damage or injury 

  

	 	12.2.2	Sony DADC’s process of manufacturing the Products (other than any part of such process which was part of the specification of the relevant Product specifically provided by the Buyer) infringes the intellectual
property rights of such third party 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	12.3	Control of Claims 

 If a party (“the Indemnified Party”) receives notice of any
claim which may be the subject of indemnity by the other party (“the Indemnifying Party”) under this clause 12: 
  

	 	12.3.1	it shall promptly notify the Indemnifying Party of such notice with all material information in its possession; 

  

	 	12.3.2	the Indemnified Party shall not admit, compromise, settle or otherwise deal with the claim or take any action in respect of it without the prior written consent of the Indemnifying Party; 

 

	 	12.3.3	following such notification the parties shall consult together as to the best course of action in respect of the claim; 

  

	 	12.3.4	save as otherwise agreed between the parties in writing, the Indemnified Party shall allow the Indemnifying Party the full conduct of the defence against the claim and shall fully co-operate with the Indemnifying Party
in respect of it (including without limitation by forwarding promptly to the Indemnifying Party all communications received by the Indemnified Party in the matter and providing all information and access to papers and personnel which are relevant to
the claim or its defence) 

  

	13.	LIMITATIONS OF LIABILITY 

  

	13.1	Force Majeure 

 The following shall apply in respect of force majeure: 

 

	 	13.1.1	in this clause 13.1 “Force Majeure Event” means in relation to either party any circumstances beyond its reasonable control (including without limitation any act of god, war, armed conflict, riot or civil
commotion, terrorist act, malicious damage, compliance with any law or government order, sequestration or appropriation of assets, fire, explosion, flood or storm, epidemic, embargo, strike or other labour dispute and restrictions on the
availability of supplies necessary for performance); 

  

	 	13.1.2	if any Force Majeure Event occurs in relation to either party which affects or will affect the performance of any of its obligations under this Agreement or under any Purchase Contract, it shall notify the other party
forthwith as to the nature and extent of the circumstances in question and the party failing or delaying performance shall use its reasonable efforts to eliminate, cure and overcome any Force Majeure Event and resume the performance of its
obligations as promptly as commercially possible; 

  

	 	13.1.3	subject to this clause 13, neither party shall be deemed to be in breach of this Agreement or of a Purchase Contract, or shall be otherwise liable to the other party, by reason only of any delay in performance, or the
non-performance, of any of its obligations there under, to the extent that the delay or non-performance is due to any Force Majeure Event of which it duly notifies the other party, and the time for performance of that obligation shall be extended
accordingly; 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	 	13.1.4	if the party fails to give notice pursuant to clause 13.1.2 it shall forfeit its rights under clause 13.1.3; 

  

	 	13.1.5	the party affected by the Force Majeure Event shall use its commercially reasonable efforts to mitigate the effects of the Force Majeure Event upon the performance of its obligations under this Agreement or the relevant
Purchase Contract; 

  

	 	13.1.6	if the performance by either party of any of its obligations under this Agreement or any Purchase Contract is prevented or delayed by a Force Majeure Event, the parties shall immediately enter into bona fide discussions
with a view to alleviating its effects; 

  

	 	13.1.7	if the performance by either party of any of its obligations under a Purchase Contract is prevented or delayed by a Force Majeure Event for thirty (30) days or more, consecutively or cumulatively in any one period
of two months, then the other party shall at its discretion have the right to terminate that Purchase Contract forthwith upon written notice; 

  

	 	13.1.8	If the Force Majeure Event will reasonably be expected to prevent Sony DADC from fulfilling its supply obligations under this Agreement for a period of greater than sixty (60) days (a “Force Majeure Supply
Failure”) 

  

	13.2	Application of Limitations 

 Nothing in this Agreement shall operate to exclude or
restrict either party’s liability for death or personal injury resulting from negligence or wilful default or for fraud or fraudulent misrepresentation or any other matter for which liability cannot effectively be excluded by law 

 

	13.3	Excluded Losses 

 Neither party shall be liable under this Agreement or any Purchase
Contract or otherwise (whether in contract, tort, misrepresentation, statutory obligation or otherwise howsoever and whether for breach of this Agreement or any Purchase Contract or under any indemnity therein) for any loss of goodwill, damage to
reputation, loss of business opportunity or anticipated saving, loss of profit, loss of business, loss of anticipated saving, loss of value of goods, loss or corruption of data or information, costs of managing and conducting the recall of Products
from customers, loss of use of any asset, business interruption or management time, third party liability, any loss which could have reasonably been avoided by the application of procedures, policies and precautions which would reasonably and
ordinarily be expected from an experienced person engaged in the industry to which the Products are relevant, or for any indirect or consequential loss or damage, provided that nothing in this clause is intended to limit the parties’ rights and
obligations under clause 12 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	13.4	Purchase Contract Limitations 

 Except under clauses 12.1.2(a) and (b) and 12.2.1(a)
and (b), the respective liability of the parties in respect of any incident arising under or in relation to a Purchase Contract (whether in contract, tort, misrepresentation, statutory obligation and whether for breach of this Agreement or any
Purchase Contract or under any indemnity therein or otherwise howsoever) shall be limited as follows: 
  

	 	13.4.1	the liability of Sony DADC (whether for non-compliance with Specification, delay, defective Product, failure to supply or otherwise and whether for negligence, breach of contract, misrepresentation or otherwise) shall
be limited to the replacement of the defective Products there under, the Buyer’s costs of returning the same to Sony DADC or destroying the same and any expedited delivery costs of the replacement Products, and in any event shall not exceed a
sum equal to one decimal point five (1.5) times the price payable to Sony DADC under that Purchase Contract (or which would be payable if that Purchase Contract were performed); 

 

	 	13.4.2	the liability of the Buyer in respect of any incident arising under a Purchase Contract (whether for negligence, breach of contract, misrepresentation or otherwise) shall not exceed a sum equal to one decimal point five
(1.5) times the price payable to Sony DADC under that Purchase Contract (or which would be payable if that Purchase Contract were performed); in addition the Buyer shall remain liable to pay the price under that Purchase Contract (if payable)

  

	13.5	General Limitation 

 All liability of each party under this Agreement and all Purchase
Contracts -whether in contract, tort, misrepresentation, statutory obligation or under any other head of claim and whether for breach or pursuant to an indemnity (except that liability under clauses 12.1.1, 12.2.1 and for breach of clauses 11.4 and
14.6 shall be unlimited)—shall not in any event exceed in respect of all events arising in the same year of this Agreement (calculated from the Commencement Date or an anniversary thereof) a sum equal to the total amount paid or payable by the
Buyer to Sony DADC in respect of all Purchase Contracts for which the Purchase Order was issued during the relevant year 
  

	14.	TERM AND TERMINATION 

  

	14.1	Term 

 Subject to the remaining provisions of this clause 14, this Agreement shall
commence on the Effective Date and shall continue in respect of each Product for the period stated in respect of that Product in Schedule 1 or (in the case of an Additional Product) stated in the relevant Product Addendum (an “Initial
Term”); the period for each Product shall 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 
commence (in the case of the Products specified in Schedule 2) on the Effective Date and (in respect of any Additional Product) on the date stated in that behalf in the relevant Product Addendum,
or if none is so stated, then upon the date on which that Product Addendum is signed by the parties. After expiry of the Initial Term in respect of a Product this Agreement shall continue until terminated in respect of that Product by the expiry of
not less than fifteen months’ notice given by either party to the other and expiring at any time after the end of the relevant Initial Term 
  

	14.2	Premature Termination 

 Either party may terminate this Agreement forthwith by giving
written notice to the other party if any of the following events occurs in relation to the other party: 
  

	 	14.2.1	subject to clause 9.3.5, the other party has committed a material breach of this Agreement which is either not capable of remedy or, if capable of remedy, has not been remedied within thirty days of notice being given
specifying the breach and requiring that it be remedied; without limiting the requirement that a breach be material for the purposes of this clause 14.2.1, a breach will not be material unless it is of such seriousness that, viewing the Agreement as
a whole on a reasonable basis and taking into account its nature and significance, the breach has deprived or is likely to deprive the terminating party of a substantial part of the benefit of this Agreement so as to warrant termination rather than
affording an opportunity to remedy and avoid repetition of the breach; 

  

	 	14.2.2	any application to court or other competent authority is made for an order, or any resolution is proposed, in either case for the winding-up, liquidation or other dissolution of the other party (save a voluntary
winding-up for the purposes of a scheme of reconstruction or amalgamation); 

  

	 	14.2.3	any application to court or other competent authority is made for any order for the appointment of an official to administer the affairs of the other party in circumstances giving protection from creditors;

  

	 	14.2.4	any order is made giving to the other party protection against creditors or relieving it from the obligation to discharge its liabilities as they fall due; 

 

	 	14.2.5	the other party is unable to pay its debts as they fall due for payment; 

  

	 	14.2.6	the other party proposes any arrangement to its creditors; 

 Sony DADC may terminate this
Agreement forthwith by giving written notice to the Buyer if the Buyer fails to pay any invoice properly issued by Sony DADC pursuant to this Agreement for more than thirty days and such invoice remains unpaid (in whole or in part) for more than
five days after written notice by Sony DADC to the Buyer requiring payment and stating that this Agreement may be terminated if it is not paid before expiry of such notice unless such invoice is the subject of a good faith dispute as referred to in
clause 8.8 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	14.3	Effect of Termination 

 If this Agreement is terminated in any manner the following shall
apply: 
  

	 	14.3.1	termination shall not affect any Purchase Contract outstanding at the date of termination unless termination is by Sony DADC pursuant to clause 14.2, in which case Sony DADC by notice to the Buyer may terminate all or
any outstanding Purchase Contracts; all Purchase Orders which have not become a Purchase Contract shall lapse; 

  

	 	14.3.2	the provisions of clauses 1, 2.3, 2.4, 5.3, 5.5, 5.6.6, 6.4, 7, 8.8, 8.9, 9.3, 11, 12, 13, 14 and 15.4 to 15.13 inclusive shall continue to have effect in accordance with their terms; termination shall not affect the
rights of either party accrued prior to the date of termination; 

  

	 	14.3.3	termination of this Agreement in respect of any one Product shall not affect the continuance of this Agreement in respect of other Products in respect of which the Agreement is not terminated 

 

	14.4	Continuance of Supply after Termination 

 The following shall apply in respect of
continuity of supply of Product to the Buyer after termination of this Agreement whilst it is establishing an alternative source of supply: 
  

	 	14.4.1	if this Agreement is terminated by notice of termination given by the Buyer under clause 14.2, Sony DADC shall continue to supply Product to the Buyer in response to Purchase Orders submitted by the Buyer within fifteen
months after the date of termination and specifying delivery on a Normal Lead Time; 

  

	 	14.4.2	all the provisions of this Agreement shall apply to the purchase and supply of Products pursuant to this clause 14.4, (and for the avoidance of doubt the provisions of clause 8 for adjustment of price shall continue to
have effect) 

  

	14.5	Suspension of Performance 

 Notwithstanding any other provision of this Agreement, Sony
DADC may refuse to accept any Purchase Order, withhold delivery and otherwise suspend its performance under this Agreement and any Purchase Contract at any time and for so long as it would be entitled to terminate this Agreement under clause 14.2 or
has reasonable grounds to believe that payment of any monies owing or which may become owing by the Buyer or any Affiliate of the Buyer to Sony DADC will not be paid when due 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	14.6	Alternate Supply 

 If the appointment of Sony DADC under clause 2.1 becomes non-exclusive
under clause 2.2.3 because of a Persistent Failure which is not cured as referred to in clause 2.2.2 or if this Agreement terminates by reason of a Force Majeure Supply Failure of Sony DADC, the following terms shall apply: 

 

	 	14.6.1	Buyer shall be entitled to designate an alternate supply source upon written notice to Sony DADC (the “Alternate Supplier”); 

 

	 	14.6.2	Sony DADC shall cooperate with Buyer to effect a smooth transfer of the manufacturing process for Product to the Alternate Supplier within [****] of such notice, including by [****] shall agree in good faith based on
the requirements of such transfer, in each case to enable the Alternate Supplier to commence production of the Product in accordance with the Specifications as soon as practicable; 

 

	 	14.6.3	[****] and its [****] may share [****] and its Affiliates to the [****] to the extent specific to the manufacture of the [****] and its supply to the [****] and the [****] shall be entitled to use such [****], in each
case for such purpose, notwithstanding anything to the contrary set forth in this Agreement or the NDA; 

  

	 	14.6.4	The [****] shall not use or disclose confidential information of [****] except for the direct purpose of obtaining [****] from the [****]. 

 

	15.	AFFILIATES 

 The following shall apply in respect of Affiliates in relation to this
Agreement: 
  

	 	15.1.1	Sony DADC may cause any Affiliate of it to perform any of its obligations under this Agreement or any Purchase Contract to be performed by any Affiliate of Sony DADC but Sony DADC undertakes with the Buyer as its own
primary obligation that it will procure that such Affiliate performs all obligations so undertaken by it, subject to the limitations of liability and other provisions of this Agreement; 

 

	 	15.1.2	any Affiliate of the Buyer may issue Purchase Orders for Products but the Buyer undertakes with Sony DADC as its own primary obligation that it will procure that any Affiliate which issues a Purchase Order duly performs
its obligations under this Agreement and the related Purchase Contract 

  

	15.2	Assignment 

 Neither party may assign this Agreement in whole or in part to any person
without the prior written consent of the other party, except (i) to an Affiliate of the Buyer or of Sony Corporation, or (ii) or in connection with a merger, consolidation, or a sale or transfer of all or substantially all of the business
or assets to which this Agreement relates; provided, that all obligations of the assigning party are assumed by the assignee; any assignment shall not relieve the assigning party of its obligations under this Agreement 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	15.3	Successors and Assigns 

 Any assignment of this Agreement in breach of the preceding
clause 15.2 shall be void and of no effect; subject thereto this Agreement shall be binding upon and enure to the benefit of the respective successors and permitted assigns of the parties 

 

	15.4	No Waiver 

 No time or other indulgence allowed by either party to the other shall
constitute any waiver of any right or remedy 
  

	15.5	Variations 

 Any variation of this Agreement shall be in writing signed by authorised
representatives of the parties and shall otherwise be of no effect 
  

	15.6	Entire Agreement 

 This Agreement represents the entire agreement between the parties in
relation to the supply of Products by Sony DADC and its Affiliates to the Buyer and its Affiliates and replaces all previous agreements between the parties in respect of that subject matter, except for any continuing agreements which Schedule 1
specifies are to continue in effect and only to the extent so specified and except for the Development and Cooperation Agreements and the NDA. Each of the parties confirms that it is not entering into this Agreement in reliance upon any
representation or warranty by the other except such representations and warranties as are contained in this Agreement; all other such representations and warranties are hereby expressly excluded 

 

	15.7	Relationship of the Parties 

 The parties are independent contractors and nothing in this
Agreement shall constitute them partners, joint venturers, co-owners, an association of entities or agents; neither party is authorised to make any statements or representations on behalf of the other party or in any way to commit the other party to
any obligation except as expressly authorised hereunder or in writing by the other party 
  

	15.8	Severability 

 If any provision of this Agreement is invalid, illegal or unenforceable
but would not be so if it were restrictively construed, it shall be so construed as to render it valid, legal and enforceable; if it is not possible to so construe it the parties shall in good faith negotiate and agree a provision to take its place
which is as close to the original provision, its purpose and effect as will be valid, lawful and enforceable. Subject to the foregoing, the invalidity, illegality or unenforceability of any provision of this Agreement shall not affect its other
provisions and this Agreement shall be given effect as if the invalid, illegal or unenforceable provision had been deleted 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	15.9	Costs and Expenses 

 Save as otherwise herein expressly provided, each party shall bear
its own costs and expenses in relation to the negotiation, preparation, execution and performance of this Agreement 
  

	15.10	Third Party Rights 

 No person other than the parties to this Agreement shall have any
right under the Contracts (Rights of Third Parties) Act 1999 to enforce any term of this Agreement 
  

	15.11	Counterparts 

 This Agreement may be executed in one or more duplicates or counterparts,
each being executed by one or more of the parties; together all such duplicates and counterparts shall constitute the same agreement 
  

	15.12	Notices 

 The following shall apply in relation to notices and other communications under
this Agreement: 
  

	 	15.12.1	any notice or other communication under this Agreement shall be in the English language, in writing (which subject to clause 15.12.4 includes facsimile transmission and electronic mail); 

 

	 	15.12.2	any notice may be given by being handed personally to an officer of the addressee and if so delivered shall be deemed to be given at the time it is handed to such person; 

 

	 	15.12.3	any notice may be given by being left at or sent by courier of good standing and repute to the address of the addressee stated in this Agreement or otherwise last known to the sender and any notice so sent shall be
deemed to be given at the time that it is physically delivered at such address; 

  

	 	15.12.4	any notice sent by facsimile transmission or by electronic mail may be given to the facsimile or electronic mail address of the address from which the sender has received a communication or acknowledgement within the
three months preceding the date of transmission of such notice or other communication and any notice or communication so sent shall be deemed to be given twelve hours after the date upon which the sending machine prints proof of the correct
transmission Provided That a notice given by facsimile or electronic mail transmission must be confirmed by written notice given in accordance with clauses 15.12.2 or 15.12.3 within ten days of the transmission and if not so confirmed it shall be of
no effect 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

	15.13	Law and Proceedings 

 This Agreement shall be governed and construed in all respects in
accordance with the laws of England and the parties irrevocably submit to the exclusive jurisdiction of the courts of England and agree that in respect of proceedings in England process may be served on either of them in the manner specified for
notices in the preceding clause 15.12 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 AS WITNESS the hands of the parties or their duly authorised representatives the date
first above written 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 SCHEDULE 1 

Contract Particulars 
 Clause 1.1
(Definitions):    The Commencement Date is the Effective Date 
 Clause 8.4.1 [****] 

Clause 8.6 [****] 
 Clause 14.1 (Term): Initial
term for each Product is [****]. 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 SCHEDULE 2 

The Product—Heatwave 
 Description:
Heat Wave cartridge for use on the RDT s RDT 1000 microdroplet platform 
 Normal lead time: [****] 

Permitted use: Research Use Only 
 Minimum shipment quantity:
[****] 
 Safety Stock: Defined as fully assembled and tested product in the quantity equal to the next three months of rolling forecasted demand as
described in Sec. 3.2. 
 Specification: The Specification is attached as Exhibit 1, which is hereby fully incorporated into this Schedule 2 to the same
effect as if it had been set out herein. 
 Initial prices: 
  

											
	 Units
	  	[****]	  	[****]	  	[****]	  	[****]	  	[****]
	 USS/Unit
	  	[****]	  	[****]	  	[****]	  	[****]	  	[****]

 The above pricing matrix applies specifically to the Heat Wave chip defined in the attached specification. [****]. 

[****]. 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

			
	 SIGNED BY
	  	)
		
	 /s/ Christoph Mauracher
	  	
	 NAME: Christoph Mauracher
	  	)
	 STATUS: Senior Vice President
	  	)
	 For and on behalf of
	  	)
	 SONY DADC AUSTRIA AG
	  	)
	 In the presence of: Harald Kraushaar
	  	)

 Witness Signature: /s/ Harald Kraushaar 

Name: Harald Kraushaar 
 Address: Sony DADC Austria AG,
Sonystrasse 20 A-5081 Anif/Salzburg 
 Occupation: Vice President 
  

			
	 SIGNED BY
	  	)
		
	 /s/ S. Roopom Banerjee

S. ROOPOM BANERJEE
	  	)
	 PRESIDENT AND CHIEF EXECUTIVE OFFICER
	  	)
	 For and on behalf of
	  	)
	 RAINDANCE TECHNOLOGIES, INC.
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Alan Sherr 

Name: Alan Sherr 
 Address: RainDance Technologies, Inc. 

44 Hartwell Avenue 
 Lexington, MA 02421 USA 

Occupation: Attorney 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 AMENDMENT AND FIRST PRODUCT ADDENDUM 

This Amendment and First Product Addendum (“First Product Addendum”) is made and entered into as of November 1, 2011 (the
“First Product Addendum Effective Date”) by and between Sony DADC Austria AG with its principal place of business at Sonystrasse 20, 5081 Anif, (“Sony DADC”), and RainDance Technologies, with its principal place of
business at 44 Hartwell Avenue, Lexington, MA 02421, USA (“RDT”), each a “Party” and together the “Parties”. 

R E C I T A L S 
 A. The
Parties entered into a Supply Agreement dated June 1, 2011 (the “Supply Agreement”). 
 B. The Parties desire to amend
the Supply Agreement as set forth below. 
 C. RDT desires to purchase from Sony DADC and Sony DADC desires to sell to RDT additional
product pursuant to the terms of the Supply Agreement. 
 A G R E E M E N T 

NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and obligations hereinafter set forth, and for
other good and valuable consideration, the adequacy and receipt of which is hereby acknowledged, the Parties agree as follows: 
  

	1.	DEFINITION. 

 “First Additional Product” means the product or products
specified in Schedule 2 attached hereto. 
  

	2.	AMENDMENT. 

 Notwithstanding [****], the Parties hereby agree that the prices [****] of
the Supply Agreement shall apply to all Purchase Contracts for any Product accepted by Sony DADC on or after the following [****]. 
  

	3.	ADDITIONAL PRODUCT. 

 3.1 Product. In accordance with clause 10.3 of the
Supply Agreement, the parties hereby agree that the First Additional Product is a “Product” for purposes of the Supply Agreement. 

3.2 Schedules. Schedules 1 and 2 attached hereto are hereby added to Schedules 1 and 2, respectively, of the Supply
Agreement. 
 3.3 Term. The term of this First Product Addendum shall commence on the First Product Addendum Effective Date.

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 3.4 General. Capitalised terms in this First Product Addendum shall have the
meanings given to such terms in the Supply Agreement unless otherwise stated. References to clauses, schedules and exhibits are to clauses, schedules and exhibits of the Supply Agreement unless otherwise stated. References to sections are to
sections of this First Product Addendum. 
 [Schedules Begin on Next Page] 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 SCHEDULE 1 

Contract Particulars 
  

			
	 Clause 8.4.1 [****]
	  	[****]
		
	 Clause 8.6    [****]
	  	[****]
		
		  	[****]
		
	 Clause 14.1

(Term):
	  	Notwithstanding anything to the contrary in the Supply Agreement, the Initial Term for the First Additional Product is [****], beginning on the First Product Addendum Effective Date.

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 SCHEDULE 2 

The First Additional Product - Thunderstorm 
  

			
	 Description:
	  	Chips for use on RDT’s Thunderstorm platform
		
	 Normal Lead Time:
	  	[****]
		
	 Permitted Use:
	  	Research Use only
		
	 Minimum

shipment quantity:
	  	[****]
		
	 Safety Stock:
	  	Defined as fully assembled and tested product in the quantity equal to the next 3 months of rolling forecasted demand as described in clause 3.2.
		
	 Specification:
	  	The Specification for the First Additional Product is attached as Exhibit 2, which is hereby fully incorporated into this Schedule 2 to the same effect as if it had been set out herein.
		
	 Initial Price:
	  	[****]
		
		  	The First Additional Product pricing matrix set forth above applies specifically to the First Additional Product. [****]
		
		  	[****].
		
	 JDA Stock:
	  	The Parties acknowledge that the aggregate price for supply of up to [****] pursuant to the Development and Cooperation Agreements (as defined in the Supply Agreement) was separately agreed therein as [****].
		
	 [****]:
	  	[****]
		
		  	[****]
		
		  	[****]
		
		  	[****]
		
		  	[****]

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 IN WITNESS WHEREOF, the Parties have entered into this First Product Addendum as of the First Product Addendum
Effective Date. 
  

			
	 SIGNED BY
  

/s/ Christoph Mauracher
	  	 )
  

	 NAME: Christoph Mauracher
	  	)
	 STATUS: Senior Vice President
	  	)
	 For and on behalf of
	  	)
	 SONY DADC AUSTRIA AG
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Harald Kraushaar 

Name: Harald Kraushaar 
 Address: Sony DADC Austria AG,
Sonystrasse 20 A-5081 Anif/Salzburg 
 Occupation: Vice President 
  

			
	 SIGNED BY
	  	)
		
	 /s/ S. Roopom Banerjee

S. ROOPOM BANERJEE
	  	)
	 PRESIDENT AND CHIEF EXECUTIVE OFFICER
	  	)
	 For and on behalf of
	  	)
	 RAINDANCE TECHNOLOGIES, INC.
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Alan Sherr 

Name: Alan B. Sherr 
 Address: 

RainDance Technologies, Inc. 
 44 Hartwell Avenue 

Lexington, MA 02421 USA 
 Occupation: 

Attorney 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 FIRST AMENDMENT TO FIRST PRODUCT ADDENDUM 

This First Amendment to First Product Addendum (“First Amendment”) is made and entered into as May 1st, 2012 (the “First Amendment Effective Date”) by and between Sony DADC Austria AG with its principal place of business at Sonystrasse 20, 5081 Anif, (“Sony DADC”),
and RainDance Technologies, with its principal place of business at 44 Hartwell Avenue, Lexington, MA 02421, USA (“RDT”), each a “Party” and together the “Parties”. 

R E C I T A L S 

A. The Parties entered into a Supply Agreement dated June 1, 2011 (the “Supply Agreement”) and entered into an
Amendment and First Product Addendum to the Supply Agreement on November 1, 2011 (the “First Product Addendum”). 

B. The Parties desire to amend the First Product Addendum as set forth below. 

A G R E E M E N T 
 NOW,
THEREFORE, in consideration of the foregoing premises and the mutual covenants and obligations hereinafter set forth, and for other good and valuable consideration, the adequacy and receipt of which is hereby acknowledged, the Parties agree as
follows: 
  

	1.	AMENDMENT. 

 1.1 Notwithstanding anything to the contrary in the First Product
Addendum, the Parties hereby agree that with respect to orders for First Additional Product placed on or after [****], (a) the pricing matrix/table (only) set out at the “Initial Price” section of Schedule 2 to the First Product
Addendum shall be of no force or effect and (b) the following pricing matrix/table shall instead apply to all such orders: 

[****] 
 1.2
Notwithstanding anything to the contrary in the First Product Addendum, the Parties hereby agree that with respect to orders for First Additional Product placed on or after [****] (a) Exhibit 2 to Schedule 2 to the First Product Addendum
shall be of no force or effect and (b) the Specification attached hereto at Schedule 1 shall apply to all such orders. 
  

	2.	GENERAL. 

 2.1 Except as expressly set forth above, all other terms and conditions of
the First Product Addendum shall remain unchanged and continue in full force and effect. This First Amendment amends and is hereby made a part of the First Product Addendum. 

2.2 This First Amendment may be signed in counterparts, each of which shall be deemed an original. Facsimile or pdf image signatures shall be
treated as original signatures. 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 2.3 Capitalised terms used in this First Amendment shall have the meanings given to such terms in
the Supply Agreement or First Product Addendum, as applicable, unless otherwise stated herein. 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 IN WITNESS WHEREOF, the Parties have entered into this First Product Addendum as of the First Product Addendum
Effective Date. 
  

			
	 SIGNED BY
	  	)
		
	 /s/ Christoph Mauracher 

CHRISTOPH MAURACHER
	  	 )
  

	 SENIOR VICE PRESIDENT
	  	)
	 For and on behalf of
	  	)
	 SONY DADC AUSTRIA AG
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Harald Kraushaar 

Name: Harald Kraushaar 
 Address: Sony DADC Austria AG,
Sonystrasse 20 A-5081 Anif/Salzburg 
 Occupation: Vice President 
  

			
	 SIGNED BY
	  	)
		
	 /s/ S. Roopom Banerjee

S. ROOPOM BANERJEE
	  	)
	 PRESIDENT AND CHIEF EXECUTIVE OFFICER
	  	)
	 For and on behalf of
	  	)
	 RAINDANCE TECHNOLOGIES, INC.
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Alan Sherr 

Name: Alan B. Sherr 
 Address: 

RainDance Technologies, Inc. 
 44 Hartwell Avenue 

Lexington, MA 02421 USA 
 Occupation: Attorney 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 SECOND AMENDMENT TO FIRST PRODUCT ADDENDUM (THUNDERSTORMTM CHIPS) TO SUPPLY AGREEMENT

 This Second Amendment to First Product Addendum (ThunderstormTM Chips) to Supply Agreement (“Second Amendment to FPA”) is
made and entered into as June 21, 2013 (the “Second Amendment Effective Date”) by and between Sony DADC Austria AG with its principal place of business at Sonystrasse 20, 5081 Anif, (“Sony DADC”), and RainDance
Technologies, with its principal place of business at 749 Middlesex Turnpike, Billerica, MA 01821, USA (“Buyer”), each a “Party” and together the “Parties”. 

R E C I T A L S 
 A. The
Parties entered into a Supply Agreement dated June 1, 2011 (as subsequently amended, the “Supply Agreement”), an Amendment and First Product Addendum to the Supply Agreement on November 1, 2011 (as subsequently amended,
the “First Product Addendum”), and the First Amendment to First Product Addendum on May 1, 2012 (the “First Amendment to FPA”). 

B. Pursuant to the First Product Addendum, Buyer purchases, and Sony DADC sells to Buyer, chips for use on Buyer’s ThunderstormTM
platform. 
 C. The Parties desire to further amend the First Product Addendum as set forth below. 

A G R E E M E N T 

NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and obligations hereinafter set forth, and for
other good and valuable consideration, the adequacy and receipt of which is hereby acknowledged, the Parties agree as follows; 
  

	1.	AMENDMENT. 

 1.1 Notwithstanding anything to the contrary in the First Product
Addendum, the Parties hereby agree that with respect to orders for First Additional Product placed on or after [****], the Specification attached to the First Amendment to FPA shall be of no force or effect and (a) the Specification attached
hereto at Schedule 1A shall apply to all such orders placed on or after [****] through and including [****] and (b) the Specification attached hereto at Schedule 1B shall apply to all such orders placed on or after [****]. 

1.2 Notwithstanding anything to the contrary in the First Product Addendum, Sony DADC shall (a) [****] when determining the volume
based unit price for the First Additional Product from [****] and (b) apply the applicable price per unit from the First Amendment to FPA in accordance with the terms of the First Product Addendum, as amended herein. The parties acknowledge and
agree that based on such [****]. For clarity, such [****] in accordance with Section [****] below. 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 1.3 Notwithstanding anything to the contrary in the [****], if during any [****] it is
determined that [****], the relevant party shall have [****] from the end of the relevant [****]. 
 1.4 Notwithstanding
anything to the contrary in the [****], as of [****], the price for each unit of the [****]. For the avoidance of doubt, such price is not subject to adjustment based on [****]. However, all units of [****]. [****] the number of units of [****].

 In connection with each [****] may request, and [****] will provide, confirmation of the number of units of [****] during the relevant [****]. Such
confirmation may include reasonable documentation. 
 1.5 Notwithstanding anything to the contrary in the First Product Addendum, the
parties hereby agree that with respect to orders for First Additional Product placed on or after [****], (a) the pricing matrix/table set out in the First Amendment to FPA shall be of no force or effect and (b) the following pricing
matrix/table shall instead apply to all such orders placed during the period of [****]: 
 [****] 

[****]. 
 The parties used an [****] when calculating the
foregoing prices. The parties agree that the [****] for purposes of the [****]. 
 1.6 Notwithstanding anything to the contrary in
the [****], the parties hereby agree that [****]. For clarity, the Parties will calculate the [****]. [****]. 
 For illustration: In
[****], the parties will calculate the [****] to be applied to the [****], based on the period of [****] shall take effect on [****]. At the same time, the parties will calculate whether [****] based on the table set forth in Section [****]. [****].
The parties shall follow the same procedure each following [****], provided that each subsequent [****] will be [****]. 
  

	2.	GENERAL. 

 2.1 Except as expressly set forth above, all other terms and conditions
of the First Product Addendum shall remain unchanged and continue in full force and effect. This Second Amendment to FPA amends and is hereby made a part of the First Product Addendum. 

2.2 This Second Amendment to FPA may be signed in counterparts, each of which shall be deemed an original. Facsimile or pdf image
signatures shall be treated as original signatures. 
 2.3 Capitalized terms used in this Second Amendment to FPA shall have
the meanings given to such terms in the Supply Agreement or First Product Addendum, as applicable, unless otherwise stated herein. 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 IN WITNESS WHEREOF, the Parties have entered into this First Product Addendum as of the First Product Addendum
Effective Date. 
  

			
	 SIGNED BY
  

/s/ Jochen Wimmer
	  	)
	 NAME: Jochen Wimmer
	  	)
	 STATUS: Vice President
	  	)
	 For and on behalf of
	  	)
	 SONY DADC AUSTRIA AG
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Alfred Paris 

Name: Alfred Paris 
 Address: Sony DADC Austria AG, Sonystrasse
20 A-5081 Anif/Salzburg 
 Occupation: Engineering Manager 
  

			
	 SIGNED BY
	  	)
		
	 /s/ S. Roopom Banerjee

S. ROOPOM BANERJEE
	  	)
	 PRESIDENT AND CHIEF EXECUTIVE OFFICER
	  	)
	 For and on behalf of
	  	)
	 RAINDANCE TECHNOLOGIES, INC.
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Alan Sherr 

Name: Alan B. Sherr 
 Address: 

RainDance Technologies, Inc. 
 44 Hartwell Avenue 

Lexington, MA 02421 USA 
 Occupation: 

Attorney 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 JUNE 2013 AMENDMENT TO SUPPLY AGREEMENT 

This June 2013 Amendment to Supply Agreement (“this June 2013 Amendment”) is entered into as of June 21, 2013
(the “June 2013 Amendment Effective Date”) by: 
  

	 	1.	Sony DADC Austria AG with its principal place of business at Sonystrasse 20, 5081 Anif (“Sony DADC”), and 

 

	 	2.	RainDance Technologies, Inc., with Its principal place of business at 749 Middlesex Turnpike, Billerica, MA 01821, USA (“Buyer”), 

each a “Party” and together the “Parties”. 

RECITALS 
 A. The Parties
entered into a Supply Agreement dated June 1, 2011 (as subsequently amended, the “Supply Agreement”). 
 B. The
Parties entered into an Amendment and First Product Addendum to the Supply Agreement dated November 1, 2011 (as subsequently amended, the “First Product Addendum”). 

C. The Parties entered into a First Amendment to First Product Addendum to the Supply Agreement dated May 1, 2012 (the
“First Amendment to FPA”). 
 D. The Parties entered into a Second Amendment to First Product Addendum
(ThunderstormTM Chips) to Supply Agreement dated on or about the date hereof (the “Second Amendment to FPA”). 

E. The Parties desire to amend the Supply Agreement as set forth below. 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the foregoing premises and the mutual covenants and obligations hereinafter set forth, and for other good and valuable consideration, the adequacy and receipt of which is hereby acknowledged, the Parties agree as
follows: 
  

	 	1.	AMENDMENT 

 1.1 Notwithstanding anything to the contrary in the Supply
Agreement, the Parties hereby agree that with respect to orders for HeatWave cartridges placed on or after [****], (a) the pricing matrix/table (only) set out at the “Initial Prices” section of Schedule 2 (The Product -HeatWave)
to the Supply Agreement shall be of no force or effect and (b) the following pricing matrix/table shall instead apply to all such orders: 
  

											
	 Units
	  	[****]	  	[****]	  	[****]	  	[****]	  	[****]
	 US$/Unit
	  	[****]	  	[****]	  	[****]	  	[****]	  	[****]

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 The prices shown in the foregoing table reflect historical currency and inflation performance. 

1.2 [****]. 
  

	 	2.	ADDRESS CHANGE 

 Notwithstanding anything to the contrary in the Supply Agreement,
Sony DADC acknowledges that as of June 1, 2013, Buyer’s address for all purposes related to the Supply Agreement shall be 749 Middlesex Turnpike, Billerica, MA 01821. 

 

	 	3.	GENERAL 

 3.1 Except as expressly set forth above, all other terms and
conditions of the Supply Agreement shall remain unchanged and continue in full force and effect. This June 2013 Amendment amends and is hereby made a part of the Supply Agreement. 

3.2 This June 2013 Amendment may be signed in counterparts, each of which shall be deemed an original, Facsimile or pdf image
signatures shall be treated as original signatures. 
 3.3 Capitalised terms used in this June 2013 Amendment shall have the
meanings given to such terms in the Supply Agreement, unless otherwise stated herein. 
 [Signature page follows] 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 IN WITNESS WHEREOF, the Parties have entered into this First Product Addendum as of the First Product Addendum
Effective Date. 
  

			
	SIGNED BY	  	)
		
	 /s/ Jochen Wimmer
	  	
	NAME: Jochen Wimmer	  	)
	STATUS: Senior Vice President	  	)
	For and on behalf of	  	)
	SONY DADC AUSTRIA AG	  	)
	In the presence of:	  	)

 Witness Signature: /s/ Alfred Paris 

Name: Alfred Paris 
 Address: Sony DADC Austria AG, Sonystrasse
20 A-5081 Anif/Salzburg 
 Occupation: Engineering Manager 
  

			
	 SIGNED BY
	  	)
		
	 /s/ S. Roopom Banerjee 

S. ROOPOM BANERJEE
	  	)
	 PRESIDENT AND CHIEF EXECUTIVE OFFICER
	  	)
	 For and on behalf of
	  	)
	 RAINDANCE TECHNOLOGIES, INC.
	  	)
	 In the presence of:
	  	)

 Witness Signature: /s/ Alan Sherr 

Name: Alan B. Sherr 
 Address: 

RainDance Technologies, Inc. 
 44 Hartwell Avenue 

Lexington, MA 02421 USA 
 Occupation: Attorney 

  
 CONFIDENTIAL TREATMENT REQUESTED
UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
COMMISSION. 

 JUNE 2014 AMENDMENT TO SUPPLY AGREEMENT 

This June 2014 Amendment to Supply Agreement (“this June 2014 Amendment”) is entered into as of June 1, 2014 (the
“June 2014 Amendment Effective Date”) by: 
  

	 	1.	Sony DADC Austria AG with its principal place of business at Sonystrasse 20, 5081 Anif, (“Sony DADC”), and 

  

	 	2.	RainDance Technologies, Inc., with its principal place of business at 749 Middlesex Turnpike, Billerica, MA 01821, USA (“Buyer”), 

each a “Party” and together the “Parties”. 

RECITALS 
  

	 	A.	The Parties entered into a Supply Agreement dated June 1, 2011 (as subsequently amended, the “Supply Agreement”). 

 

	 	B.	The Parties entered into an Amendment and First Product Addendum to the Supply Agreement dated November 1, 2011 (as subsequently amended, the “First Product Addendum”). 

 

	 	C.	The Parties entered into a First Amendment to First Product Addendum to the Supply Agreement dated May 1, 2012 (the “First Amendment to FPA”). 

 

	 	D.	The Parties entered into a Second Amendment to First Product Addendum (ThunderstormTM Chips) to Supply Agreement dated June 21, 2013 (the “Second Amendment to FPA”). 

 

	 	E.	The Parties entered into a June 2013 Amendment to Supply Agreement dated June 21, 2013 (the “June 2013 Amendment”). 

 

	 	F.	The Parties entered into a Third Amendment to First Product Addendum (ThunderstormTM Chips) to Supply Agreement dated on or about the date hereof (the “Third Amendment to FPA”). 

 

	 	G.	The Parties desire to further amend the Supply Agreement as set forth below. 

 AGREEMENT

 NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and obligations hereinafter set forth, and for
other good and valuable consideration, the adequacy and receipt of which is hereby acknowledged, the Parties agree as follows: 
  

	1.	AMENDMENT. 

 Notwithstanding anything to the contrary in the Supply Agreement, the
Parties hereby agree that (a) with respect to shipments of Heatwave cartridges snipped on or after [****], the 

 
pricing matrix/table (only) set out at the “Initial Prices” section of Schedule 2 (The Product - Heatwave) to the Supply Agreement and the price table for Heatwave cartridges set out in
any amendment to the Supply Agreement shall be of no force or effect and (b) the following pricing matrix/table shall instead apply to all shipments of Heatwave cartridges shipped during the period of [****] through [****]: 

 

													
	 Units
	  	 	[****]	  	  	 	[****]	  	  	 	[****]	  
	 US$/Unit
	  	 	[****]	  	  	 	[****]	  	  	 	[****]	  

 The prices shown in the foregoing table reflect historical currency and inflation performance. 

 

	2.	GENERAL. 

 2.1 Except as expressly set forth above, all other terms and conditions of the
Supply Agreement shall remain unchanged and continue in full force and effect. This June 2014 Amendment amends and is hereby made a part of the Supply Agreement. 

2.2 This June 2014 Amendment may be signed in counterparts, each of which shall be deemed an original. Facsimile or pdf image signatures shall
be treated as original signatures. 
 2.3 Capitalised terms used in this June 2014 Amendment shall have the meanings given to such terms in
the Supply Agreement, unless otherwise stated herein. 
 IN WITNESS WHEREOF, the Parties have entered into this June 2014 Amendment as of the June
2014 Amendment Effective Date: 
 SIGNED BY: 
  

	
	/s/ Jochen Wimmer
	 NAME: Jochen Wimmer
 STATUS: VP
Operations
 For and on behalf of
 SONY DADC AUSTRIA
AG
 In the presence of:

 Witness Signature: 
 Name:
Dr. Ali Tinazli 
 Address: 1 Mifflin Place, Cambridge, MA 02138 

Occupation: VP Bus Dev 

 SIGNED BY 
  

	
	/s/ S. Roopom Banerjee
	 S. ROOPOM BANERJEE

PRESIDENT AND CHIEF EXECUTIVE OFFICER
 For and on behalf
of
 RAINDANCE TECHNOLOGIES, INC.
 In the presence
of:

 Witness Signature: /s/ Alan B. Sherr 

Name: 
 Alan B. Sherr 

Address: 
 RainDance Technologies, Inc. 

749 Middlesex Turnpike 
 Billerica, MA 01821 

USA 
 Occupation: 

Attorney 

  
 3EX-10.22

 Exhibit 10.22 

EXCLUSIVE LICENSE AGREEMENT 

BETWEEN THE UNIVERSITY OF CHICAGO AND RAINDANCE TECHNOLOGIES 

FOR MICROFLUIDIC TECHNOLOGY 
 This License
Agreement (“Agreement”), dated June 9, 2008, is between The University of Chicago, an Illinois not-for-profit corporation (“UNIVERSITY”), and RainDance Technologies, a Delaware corporation, having an address at 44 Hartwell
Ave., Lexington, MA 02421 (“RAINDANCE”). Each hereunder maybe referred to separately as the (“Party”), or together as the (“Parties”). 

WHEREAS, UNIVERSITY has the authority to issue licenses under Licensed Patents, and 

WHEREAS, RAINDANCE wishes to obtain a license under the Licensed Patents, and 

WHEREAS, RAINDANCE is prepared and intends to diligently develop the invention and to bring products to market which are subject to this Agreement, and 

WHEREAS, research leading to Licensed Patents was sponsored in part by grants from the U.S. Government, and 

NOW, THEREFORE, for good and valuable consideration, the Parties agree as follows: 

Section 1. Definitions 
 The
capitalized terms listed below and used in this Agreement shall have the following meanings: 
  

	 	A.	“Affiliate” means any corporation or other business entity that controls, is controlled by, or is under common control with a Party. A corporation or other entity shall be regarded as in control of another
corporation or entity if it owns or directly or indirectly controls at least fifty percent (50%) of the outstanding shares or other voting rights of the other corporation or entity having the right to elect directors or such lesser percentage
that is the maximum permitted to be owned by a foreign entity in those jurisdictions where majority ownership by foreign entities is prohibited. 

  

	 	B.	[****]. 

  

	 	C.	“Effective Date” means the date first written on page one of this Agreement. 

  

	 	D.	“Field” means [****]: 

  

	 	i.	[****]. 

  

	 	ii.	[****]. 

  

	 	iii.	[****]. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 [****] 
  

	 	E.	“First Commercial Sale” means the first sale or transfer of a Licensed Product by RAINDANCE or its Affiliate to a third party for consideration. 

 

	 	F	“Licensed Patent(s)” means the patents and patent applications listed on Schedule A attached hereto, including all divisions, continuations, continuations-in-part, foreign counterparts, and any valid patents
which may issue worldwide from such patent applications and any reissues, renewals, substitutions, or extensions of or to any such patents or patent applications. 

 

	 	G.	“Licensed Product” means services, products, including systems, chips, and kits which are (i) covered by the scope of any Valid Claim contained in any Licensed Patent, (ii) are made by a process,
method or technique covered by the scope of any Valid Claim in any Licensed Patent, (iii) used in a method of use covered by the scope of any Valid Claim in any Licensed Patent, (iv) made using a component or material that is covered by
the scope of any Valid Claim contained in any Licensed Patent that is supplied or caused to be supplied from, or offered for sale, sold or imported into, the United States, or (v) used in any service or part of selling a service, covered by the
scope of any Valid Claim contained in the Licensed Patents. 

  

	 	H.	“Net Sales” means the amount billed, invoiced or received (whichever occurs first) for sales, leases or other transfers or use of Licensed Products, or any right, title or interest in Licensed Products, less
the following amounts: 

  

	 	i.	customary trade, quantity or cash discounts and rebates actually allowed and taken; 

  

	 	ii.	amounts repaid or credited to customers on account of rejections or returns; and 

  

	 	iii.	to the extent separately stated on purchase orders, invoices, or other documents of sale, taxes levied on production, sale, transportation, delivery or use and paid by or on behalf of RAINDANCE or Sublicensees; and

  

	 	iv.	reasonable charges for delivery or transportation provided by third parties, if separately stated. 

 Net Sales
also includes the fair market value of any non-cash consideration received by RAINDANCE or Sublicensees for the sale, lease or other transfers or use of Licensed Products, or any right, title or interest in Licensed Products. Fair market value will
be calculated as of the time of transfer of such non-cash consideration to RAINDANCE. Transfer of a Licensed Product within RAINDANCE or between RAINDANCE and an Affiliate or Sublicensee for sale by the transferee shall not be considered a Net Sale
for purposes of calculating Royalties. In such 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 
circumstances, the gross sales price and resulting Net Sales price shall be based upon the sale of the Licensed Product by the transferee. For Licensed Products consumed by RAINDANCE, a
Sublicensee or Affiliates of either to perform commercial services, the price used to calculate Net Sales shall be equal to the list price of the same or a substantially similar Licensed Product. Licensed Products consumed by RAINDANCE or Affiliates
for internal research and development shall not be considered a Net Sale. Any transfer of Licensed Products in the seeking of regulatory approval or as free samples shall be considered a Net Sale at fair market value calculated at of the time of
such transfer. 
  

	 	I.	[****] 

  

	 	i.	

 [****] 

[****] 
 [****]. 

[****]. 
  

	 	ii.	

 [****]. 

[****]. 
 [****]. 

 

	 	J.	“Royalty(ies)” means all amounts payable under Section 3.B of this Agreement. 

  

	 	K.	“Sublicense” means any agreement entered into by RAINDANCE with any third party (including Affiliates of RAINDANCE) for which any right, title or interest to the Licensed Patents is granted. 

 

	 	L.	 “Sublicense Revenue” means any kind of compensation or consideration, including any payments made by a third party to RAINDANCE on behalf of
a Sublicensee, except Royalties (which are subject to Section 3.B), to which RAINDANCE is entitled in connection with the grant of any rights or interest to a Sublicensee, without regard to how the compensation or consideration is structured,
denominated or paid. Sublicense Revenue includes all fees, minimum royalties, milestone payments and other payments or consideration of any kind including without limitation in kind payments, equity amounts taken by RAINDANCE in lieu of cash, or
discounts below fair market value of an equity purchase by RAINDANCE. Notwithstanding the foregoing, Sublicense Revenue shall not include proceeds reasonably and fairly attributable, as determined in

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	
good faith by LICENSEE, to bona fide: (i) equity investments in the LICENSEE at fair market value; and (ii) reimbursement for the cost of research and/or development services provided
on the basis of full-time equivalent efforts of personnel not in excess of commercially reasonable full-time equivalent rates. 

  

	 	M.	“Sublicensee” means any person, company or other entity granted a Sublicense by RAINDANCE under Section 2.B below, including Affiliates of any such person, company or entity. 

 

	 	N.	“Territory” means [****]. 

  

	 	O.	“Valid Claim” means an issued claim of any unexpired patent which has not been held unenforceable, unpatentable or invalid by a decision of a court or governmental body of competent jurisdiction, in a ruling
that is unappealable or unappealed within the time allowed for appeal. 

 Section 2. Grant 

 

	 	A.	Grant. Upon payment of the license payments described in Section 3. A and Section 6.B.i, and subject to and conditioned on RAINDANCE’s continuing compliance with the terms and conditions of this
Agreement, UNIVERSITY hereby grants to RAINDANCE and its Affiliates an exclusive license to [****]. 

  

	 	B.	Sublicense. RAINDANCE shall have the right to grant Sublicenses to third parties to the rights granted RAINDANCE under Section 2.A. As an express condition precedent to RAINDANCE’s right to grant any
Sublicense to a third party: (i) the terms of the Sublicense shall be consistent and in no way conflict with this Agreement; (ii) the Sublicense shall provide that the Sublicensee may not grant further Sublicenses to third parties, except
for Affiliates and bona fide marketing or distribution partners of the Sublicensee; and (iii) the Sublicense shall contain all essential terms and conditions of this Agreement. Any Sublicense that does not meet each of (i)-(iii) above is
void ab initio. 

  

	 	C.	Reservation of Rights. [****]. 

  

	 	D.	U.S. Laws. The inventions claimed in the Licensed Patents were developed with the use of United States Government funds. Therefore, all rights granted in this Agreement are subject to the provisions of Public Law
96-517 (The Bayh-Dole Act of 1980), Public Law 98-620 (The Trademark Clarification Act of 1984) and/or any other applicable law concerning rights in inventions developed with the use of United States Government funds. 

 

	 	E.	No Other Rights. No rights in and to the Licensed Patents other than those provided in this Section 2, express or implied, are conveyed by UNIVERSITY. No rights to any patents except those included in
Licensed Patents are conveyed by UNIVERSITY. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 Section 3. Payments 
  

	 	A.	Upfront Payment. As partial consideration for the exclusive license granted in Section 2 of this Agreement, RAINDANCE shall pay UNIVERSITY concurrently with execution of this Agreement the sum of [****] U.S.
dollars. 

  

	 	B.	Royalties. As partial consideration for the exclusive license granted in Section 2 of this Agreement, RAINDANCE shall pay UNIVERSITY a Royalty equal to: 

 

	 	i.	[****] of Net Sales of [****] that are Licensed Products, payable by RAINDANCE, its Sublicensees and Affiliates of either, and 

  

	 	ii.	[****] of Net Sales of [****] that are Licensed Products, payable by RAINDANCE, its Sublicensees and Affiliates of either, and 

  

	 	iii.	[****] of Net Sales of [****] that are Licensed Products, payable by RAINDANCE, its Sublicensees and Affiliates of either. 

Notwithstanding the foregoing, in the event RAINDANCE, Sublicensees or Affiliates are required to make patent royalty payments, at fair market
terms, to a third party as a result of the sale of Licensed Products, RAINDANCE may offset such third party payments against the royalty payments that are due to UNIVERSITY, provided that in no event shall the royalty payments to UNIVERSITY be
reduced to less than [****] to less than [****] for [****], and to less than [****] for [****]. 
  

	 	C.	Accrued Royalties on Newly Licensed Products. When Net Sales of a product or service are accrued at a time during the pendency of an application(s) within the Licensed Patents, but prior to the issuance of a
Valid Claim (“Prior Pendency”), and a Valid Claim subsequently issues that covers the product or service sold during such Prior Pendency, then LICENSEE, as partial consideration for the license granted in Section 2, shall pay
UNIVERSITY, within [****] of the issuance of such Valid Claim, a lump sum payment equal to [****] of the cumulative Royalties on all Net Sales of newly Licensed Product accrued during such Prior Pendency. For the avoidance of doubt, such cumulative
Royalties are due if such product or service is (i) covered by the scope of the Valid Claim, (ii) made by a process, method or technique covered by the scope of the Valid Claim, (iii) used in a method of use covered by the scope of
the Valid Claim, (iv) made using a component or material that is covered by the scope of the Valid Claim that is supplied or caused to be supplied from, or offered for sale, sold or imported into, the United States, or (v) used in any
service or part of selling a service, covered by the scope of the Valid Claim. For the further avoidance of doubt, such cumulative Royalties are not due for a particular Net Sale if Royalties were already paid on such Net Sale during the Prior
Pendency. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	D.	License Maintenance Fees/Minimum Royalties. RAINDANCE shall pay UNIVERSITY the sum of [****] U.S. dollars annually on each anniversary date of the date first written on page one of this Agreement until [****]. If
the total Royalties for any annum beginning with the [****] of First Commercial Sale of a Licensed Product in the United States, are less than 

  

	 	i.	[****], 

  

	 	ii.	[****], and 

  

	 	iii.	[****], then 

 [****]. Such payment shall be made at the same time the payment for Royalties for
the annum are due. If no Royalties are being paid by RAINDANCE for any annum in which minimum Royalties are due and payable, the minimum Royalties shall be paid within thirty (30) days of the end of each such annum. 

 

	 	E.	Payment and Reporting of Royalties. Royalties shall be payable in U.S. currency within thirty (30) days after the end of each [****]during the term of this Agreement, beginning with the [****]. Any necessary
conversion of currency into United States dollars shall be at the applicable rate of exchange of Citibank, N.A., in New York, New York, on the last day of the [****] in which such transaction occurred. Each payment shall be accompanied by a
statement, verified and signed by the President or Chief Financial Officer of RAINDANCE and certified as accurate, showing Net Sales for each country in the Territory and calculation of the Royalties due. 

 

	 	F.	RAINDANCE Responsibility for Payments. RAINDANCE shall be responsible for obtaining the full compliance of its Affiliates and Sublicensees with the terms and conditions of this Agreement and any Sublicense. For
the purposes of payments, RAINDANCE shall be fully responsible for any payments due to UNIVERSITY under this Agreement that are not made by its Affiliates and/or its Sublicensees according to the terms of this Agreement. Time is of the essence with
respect to all payments made by RAINDANCE to UNIVERSITY. 

  

	 	G.	Sublicense Payments. UNIVERSITY will be paid [****] of all Sublicense Revenue in connection with the Sublicense of technology that is both (i) covered by at least one Valid Claim in a Licensed Patent and
(ii) not covered by one or more Valid Claims of a patent which is owned by RAINDANCE or licensed to RAINDANCE by a third party. For each Sublicense granted by RAINDANCE that includes patents from UNIVERSITY and patents from additional parties,
UNIVERSITY will be paid [****] of the Sublicense Revenue that is fairly allocated to the value of the Licensed Patents under this Agreement. Any such payments to UNIVERSITY will be accompanied by a statement explaining in detail the basis of the
allocation. All payments made under this paragraph shall be made (or assigned as relevant) to UNIVERSITY within [****] by RAINDANCE, and will be subject to Section 5.A. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	H.	Overdue Payments. Payments due to UNIVERSITY under this Agreement shall, if not paid when due under the terms of this Agreement, bear simple interest at the lower of the prime rate of interest (as published by
Citibank, N.A. on the date such payment is due) plus [****] or the highest rate permitted by law, calculated on the basis of a 360-day year for the number of days actually elapsed, beginning on the due date and ending on the day prior to the day on
which payment is made in full. Interest accruing under this Section 3.G shall be due to UNIVERSITY on demand or upon payment of past due amounts, whichever is sooner. The accrual or receipt by UNIVERSITY of interest under this Section 3.G
shall not constitute a waiver by UNIVERSITY of any right it may otherwise have to any other remedies available to UNIVERSITY including the right to declare a default under this Agreement or to terminate this Agreement. RAINDANCE shall pay for all
costs and fees including reasonable attorney’s fees that UNIVERSITY must expend in order to collect any amounts due and owing to UNIVERSITY after reasonable attempts have been made to collect the amounts or, in UNIVERSITY’S discretion,
after the amounts remain outstanding for a period of ninety (90) days from the payment due date. 

 Section 4. Diligence 

 

	 	A.	Efforts. RAINDANCE shall use reasonable efforts to exploit the licenses granted herein by diligently developing the invention and to bring Licensed Products to market which are subject to this Agreement.

  

	 	B.	[****]. 

  

	 	C.	Promotion and Marketing. RAINDANCE shall use reasonable efforts (and in no event less effort or relative expense than RAINDANCE expends in promoting its other products) to promote, advertise, and sell the
Licensed Products. 

 Section 5. Records and Reporting 
  

	 	A.	 Full and Accurate Records. UNIVERSITY may from time to time and at any reasonable time, not exceeding once every twelve (12) months,
through individuals as UNIVERSITY may designate, inspect the books and records of RAINDANCE and its Affiliates in order to verify the accuracy of any reported statement by RAINDANCE of sums paid or payable, or of any other material obligation under
this Agreement. RAINDANCE shall keep, and shall cause its Affiliates and Sublicensees to keep, full and accurate books and records in sufficient detail so that RAINDANCE’s compliance with its obligations under this Agreement can be properly
determined without undue delay or difficulty. Such books and records shall be maintained for at least five (5) years after the Royalty reporting period(s) to which they relate. Books and records shall include but not

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	
be limited to: accounting general ledgers; invoice/sales registers; original invoice and shipping documents; federal and state business tax returns; company financial statements; sales analysis
reports; inventory and or manufacturing records; sublicense and distributor agreements; price lists, product catalogs and other marketing materials; and laboratory notebooks. 

After completion of any such examination, UNIVERSITY shall promptly notify RAINDANCE in writing of any proposed modification to
RAINDANCE’s statement of sums due and payable. Such examination shall be made at the expense of UNIVERSITY, unless such examination discloses a discrepancy of [****] or more in the amount of Royalties and other payments due UNIVERSITY. In such
case RAINDANCE shall be responsible for reimbursing UNIVERSITY for the examination fee and expenses charged by the auditor. Any underpayment as determined by the auditor will bear interest at [****] per month from the date the royalty payment was
due. RAINDANCE agrees to pay past due royalties for any royalty deficiency error as determined by the auditor, including any royalty deficiency for periods prior to the period under audit. UNIVERSITY and the auditor shall maintain in confidence such
inspection and the resulting report. The auditor may from time to time consult the UNIVERSITY and any of its employees or third party counsel on questions as they relate to the Agreement. The auditor may not disclose financial or proprietary
information except as required to conduct the audit, to report the results of the audit, or as otherwise permitted by this Agreement or if the information already exists in the public domain. No other confidentiality agreement shall be required to
conduct the audit of the RAINDANCE’s books and records. 
  

	 	B.	Progress Reports. Within thirty (30) days of the end of each calendar year during the term of this Agreement, RAINDANCE shall make a written report to UNIVERSITY, in such detail as UNIVERSITY may reasonably
request, covering the preceding year and describing the progress of RAINDANCE toward bringing Licensed Products to market (and any proposed revisions to the plan developed during the preceding year). RAINDANCE agrees to immediately notify UNIVERSITY
in writing upon First Commercial Sale of each Licensed Product [****]. Upon the First Commercial Sale of each Licensed Product, RAINDANCE shall provide in writing to UNIVERSITY the date of First Commercial Sale and the tradename of each commercial
product. 

 Section 6. Patents 
  

	 	A.	 Prosecution and Maintenance. [****] shall be solely responsible for the preparation, filing, prosecution, maintenance and abandonment of the
Licensed Patents. [****] agrees to cooperate, and to cause [****], with [****] in a timely manner in the preparation, filing, prosecution and maintenance of the Licensed Patents by disclosing such information as may be requested by [****] and by
promptly executing such documents as [****] may reasonably request in 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	
connection therewith. [****] of either shall bear their own costs in connection with their cooperation with under this Paragraph. [****] will make reasonable efforts to provide, or to have their
legal counsel provide, [****] copies of all material documents received or prepared by [****] in the prosecution and maintenance of the Licensed Patents prior to such documents being filed in any patent office and giving [****] reasonable time to
comment thereon. [****] shall file additional claims, in existing cases or in divisional or continuing applications, upon [****] reasonable request. 

  

	 	B.	Patent Costs. [****] agrees to pay all necessary and reasonable fees and expenses incurred by [****] in preparing, filing, prosecuting and maintaining the Licensed Patents (“Patent Costs”), except where
a [****] in which case [****]. In the event [****]. 

  

	 	i.	RAINDANCE shall pay [****]. 

  

	 	ii.	[****]. 

  

	 	iii.	[****]. 

  

	 	iv.	[****]. 

  

	 	C.	Infringement. In the event of an alleged infringement of a Licensed Patent the following shall apply: 

  

	 	i.	Notice. Each party shall give the other written notice if one of them becomes aware of any alleged infringement by a third party of any Licensed Patent. Upon notice of any such alleged infringement, the parties
shall promptly consult with one another with a view toward reaching agreement on a course of action to be pursued. 

  

	 	ii.	[****]. 

  

	 	(1)	[****]. 

  

	 	(2)	[****]. 

  

	 	iii.	[****]. 

 Section 7. Term and Termination 

 

	 	A.	Term. Unless terminated earlier, this Agreement shall expire on the expiration date of the last to expire of the Licensed Patents. 

 

	 	B.	UNIVERSITY’S Right to Terminate. UNIVERSITY shall have the right to terminate this Agreement as follows, in addition to all other available remedies: 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	i.	If RAINDANCE fails to make any Royalty or other payment (whether of cash, stock or other form of consideration) when due, UNIVERSITY may terminate this Agreement thirty (30) days after UNIVERSITY’S written
notice to RAINDANCE describing such failure, unless RAINDANCE makes such payment within such thirty (30) days, unless RAINDANCE disputes that such payment is in fact owed (in which case the Parties shall make reasonable attempts to resolve the
dispute by discussion, mediation, arbitration and/or other available routes for dispute resolution). 

  

	 	ii.	If RAINDANCE breaches any obligation of this Agreement other than an obligation to make a Royalty or other payment when due, this Agreement shall terminate effective sixty (60) days after UNIVERSITY’S written
notice to RAINDANCE describing such failure, unless RAINDANCE cures such failure to the satisfaction of UNIVERSITY within such sixty (60) days. 

  

	 	iii.	If RAINDANCE shall have filed by or against it a petition under any bankruptcy or insolvency law it shall immediately notify UNIVERSITY. If such petition is not dismissed within sixty (60) days of its filing, or if
RAINDANCE makes an assignment of all or substantially all of its assets for the benefit of its creditors, RAINDANCE shall immediately notify UNIVERSITY and UNIVERSITY may terminate this Agreement by written notice effective as of the (i) date
of filing by RAINDANCE of any such petition, (ii) date of any such assignment to creditors, or (iii) end of the sixty (60) days if a petition is filed against it and not dismissed by such time, whichever is applicable.

  

	 	iv.	If RAINDANCE shall be dissolved, liquidated or otherwise ceases to exist, other than for reasons specified in Section 7.B.(iii) above, this Agreement shall automatically terminate as of (i) the date articles
of dissolution or a similar document is filed on behalf of RAINDANCE with the appropriate government authority or (ii) the date of establishment of a liquidating trust or other arrangement for the winding up of the affairs of RAINDANCE .

  

	 	C.	RAINDANCE’s Right to Terminate. RAINDANCE may notify UNIVERSITY of its desire to terminate this Agreement at any time by giving UNIVERSITY ninety (90) days prior written notice. The termination shall
take effect at the end of the first royalty reporting period after the ninetieth day has elapsed. 

  

	 	D.	Survival. The following shall survive any termination of this Agreement for any reason: (i) all causes of action accruing to either party under this Agreement, (ii) RAINDANCE’s obligation to pay
Royalties, Patent Costs, and all other amounts payable under this Agreement accrued prior to the date of termination, (iii) RAINDANCE’s obligation to report Net Sales and keep records, as required by Section 5;
(iv) UNIVERSITY’S right to request an audit pursuant to Section 5.A; and (v) Sections 5, 7.E, 8, and 9 of this Agreement. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	E.	Post Termination, Post Expiration Obligations of RAINDANCE. Upon the termination of this Agreement for any reason, except expiration of this Agreement pursuant to Section 7.A., all rights of RAINDANCE to use
the Licensed Patent(s) shall immediately thereafter cease. RAINDANCE shall not thereafter operate or conduct business under any name or mark and in any manner in the Territory that might tend to create the impression that this Agreement is still in
force, or that RAINDANCE has any right to use any Licensed Patent(s), any trademark or servicemark of UNIVERSITY, and/or any tangible property owned by UNIVERSITY in the Territory. Upon termination or expiration, all payments including fees and
costs due under this Agreement and not paid yet shall become immediately due and payable. 

  

	 	F.	Termination and Sublicenses. Each Sublicense shall state that if this Agreement terminates for any reason, except expiration pursuant to Section 7.A, the Sublicense shall automatically terminate effective
the same date without the necessity of any prior notice to Sublicensee , either from UNIVERSITY, RAINDANCE or otherwise. In each case, UNIVERSITY agrees upon request of each Sublicensee not then in material breach of any provisions of this Agreement
applicable to such Sublicensee promptly enter into a direct license agreement with such Sublicensee on terms substantially the same as the terms of this Agreement. . If, however, no such agreement is reached within one hundred and eighty
(180) days, or a longer, mutually agreed upon time period, UNIVERSITY shall have no further obligation to the Sublicensee. 

Section 8. Representations, Warranties, Disclaimers; Indemnification; Insurance 

 

	 	A.	Representations, Warranties and Covenants of RAINDANCE. RAINDANCE hereby represents, warrants and covenants that: 

  

	 	i.	RAINDANCE is a corporation duly organized, validly existing and in good standing under the laws of Delaware, has the corporate power and authority to execute and deliver this Agreement, and perform its obligations under
this Agreement. 

  

	 	ii.	The execution, delivery and performance have been duly and validly authorized by RAINDANCE, and upon execution and delivery by RAINDANCE, this Agreement will constitute a valid and binding agreement of RAINDANCE.

  

	 	iii.	RAINDANCE has no other agreements that conflict with the obligations undertaken and rights and licenses granted in this Agreement. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	iv.	Any manufacture of Licensed Product(s) by RAINDANCE, its vendor(s), suppliers agents or contractors, shall comply with and conform to all applicable specifications required by any regulatory approval. 

 

	 	v.	RAINDANCE and its Affiliates will take no action nor engage in any activity that substantially increases the risk that any Licensed Patent or any claim in any Licensed Patent is likely to be found invalid or
unenforceable. 

  

	 	vi.	RAINDANCE shall timely make all payments to UNIVERSITY required by this Agreement. 

  

	 	B.	Disclaimer of Warranties. UNIVERSITY MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, UNDER THIS AGREEMENT. IN PARTICULAR , UNIVERSITY DISCLAIMS ANY WARRANTY WITH RESPECT TO THE
INVENTION(S) CLAIMED IN THE LICENSED PATENTS OR WITH RESPECT TO THE LICENSED PATENTS THEMSELVES, INCLUDING BUT NOT LIMITED TO, ANY REPRESENTATIONS OR WARRANTIES ABOUT (I) THE VALIDITY, SCOPE OR ENFORCEABILITY OF ANY OF THE LICENSED PATENTS;
(II) THE ACCURACY, SAFETY OR USEFULNESS FOR ANY PURPOSE OF ANY INFORMATION PROVIDED BY UNIVERSITY TO RAINDANCE, ITS SUBLICENSEES, OR AFFILIATES OF EITHER, WITH RESPECT TO THE INVENTION(S) CLAIMED IN THE LICENSED PATENTS OR WITH RESPECT TO THE
LICENSED PATENTS THEMSELVES AND ANY PRODUCTS DEVELOPED FROM OR COVERED BY THEM; (III) WHETHER THE PRACTICE OF ANY CLAIM CONTAINED IN ANY OF THE LICENSED PATENTS WILL OR MIGHT INFRINGE A PATENT OR OTHER INTELLECTUAL PROPERTY RIGHT OWNED OR LICENSED
BY A THIRD PARTY; (IV) THE PATENTABILITY OF ANY INVENTION CLAIMED IN THE LICENSED PATENTS; OR (V) THE ACCURACY, SAFETY, OR USEFULNESS FOR ANY PURPOSE OF ANY PRODUCT OR PROCESS MADE OR CARRIED OUT IN ACCORDANCE WITH OR THROUGH THE USE OF THE
LICENSED PATENTS. IN ADDITION, UNIVERSITY SPECIFICALLY DISCLAIMS ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. 

  

	 	C.	[****]. 

  

	 	D.	[****]. 

  

	 	E.	 Insurance. RAINDANCE agrees, and agrees to cause its Sublicensees and Affiliates of either to agree, to maintain liability insurance that shall
cover any claims for bodily injury, property, or other damage alleged to relate to Licensed Products or activities undertaken in connection with this Agreement, Licensed Patents, or Licensed Products, including the development, manufacture, use,
sale 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	
or other disposition of Licensed Products and all activities associated therewith. RAINDANCE, Sublicensees and Affiliates of either shall list UNIVERSITY and its Affiliates, at RAINDANCE’s,
Sublicensee’s or Affiliates’ expense, whichever is relevant, as additional named insureds under each liability insurance policy (including excess or umbrella liability policies) that RAINDANCE, its Sublicensees or Affiliates have or shall
obtain, that includes any coverage of claims relating to Licensed Products. Such insurance shall be primary and noncontributory to any insurance UNIVERSITY and its Affiliates may have. At UNIVERSITY’S request, RAINDANCE will supply UNIVERSITY
from time to time with copies of each such policy. 

 Section 9. Miscellaneous 

 

	 	A.	Marking. RAINDANCE shall place, and agrees to cause its Sublicensees and Affiliates of either to place, in a conspicuous location on Licensed Products (or its packaging where marking the Product is physically
impossible) a patent notice in accordance with the laws concerning the marking of patented articles in the country in which such articles are sold. 

  

	 	B.	US Manufacture. RAINDANCE agrees that any Licensed Products will be manufactured substantially in the United States of America as required by 35 United States Code Section 204. 

 

	 	C.	Export Regulations. Licensed Products and technical data and information delivered under this Agreement may be subject to United States export control laws and may also be subject to export or import regulations
in other countries. RAINDANCE agrees to comply strictly with all such laws and regulations and acknowledges that RAINDANCE has the responsibility to obtain such licenses to export, re-export, or import Licensed Products or other technical data and
information delivered under this Agreement as may be required by applicable laws or regulations. RAINDANCE shall not knowingly export or re-export or cause to be exported or re-exported, directly or indirectly, any Licensed Products, or any
documents, materials or information related to the development, commercialization, marketing, use or sale of any Licensed Product, to any country for which the United States government or any other government, or any agency thereof, requires an
export license or other government approval at the time of such export without first obtaining any required license or approval. 

  

	 	D.	Entire Agreement, Amendment, Waiver. This Agreement together with the Schedules attached hereto constitutes the entire agreement between the parties regarding the subject matter hereof, and supersedes all prior
written or oral agreements or understandings (express or implied) between them concerning the same subject matter. This Agreement may not be amended or modified except in a document signed by duly authorized representatives of each party. No waiver
of any default hereunder by either party or any failure to enforce any rights hereunder shall be deemed to constitute a waiver of any subsequent default with respect to the same or any other provision hereof. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	E.	Notice. Any notice required or otherwise made pursuant to this Agreement shall be in writing, sent by registered or certified mail properly addressed, or by facsimile with confirmed answerback, to the other party
at the address set forth below or at such other address as may be designated by written notice to the other party. Notice shall be deemed effective three (3) business days following the date of sending such notice if by mail, on the day
following deposit with an overnight courier, if sent by overnight courier, or upon confirmed answer-back if by facsimile. 

  

			
	If to UNIVERSITY:	  	UChicagoTech
		  	Office of Technology and Intellectual Property
		  	The University of Chicago
		  	5555 South Woodlawn Avenue
		  	Suite 300
		  	Chicago, Illinois 60637
		
		  	Facsimile Number: 773-702-0741
		  	Attention: Director of Technology Transfer
		
	If to RAINDANCE:	  	
		
		  	Attn: CEO
		  	Raindance
		  	44 Hartwell Ave.
		  	Lexington, MA 02421
		  	781-861-6300 phone
		  	781-861-1233 fax
		
	With a Copy to:	  	
		
		  	Ivor Elrifi
		  	MINTZ LEVIN
		  	666 Third Avenue
		  	New York, NY 10017
		
		  	212 692 6800 phone
		  	212 983 3115 fax

  

	 	F.	 Assignment. This Agreement shall be binding on the parties hereto and upon their respective successors and assigns. RAINDANCE may at any time,
upon written notice to the other party, assign or delegate to a successor to all or substantially all of its business any of its rights and obligations hereunder, provided that, any such assignment or delegation shall in no event relieve RAINDANCE
of its primary 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	
responsibility for the same. Any such assignment shall be conditioned on and shall not be effective until the assignee or transferee has executed and delivered a written agreement assuming and
undertaking all of the duties and obligations of the assignor or transferor under this Agreement. Except as provided above, RAINDANCE may not assign or delegate any right or obligation hereunder without the prior written consent of UNIVERSITY, which
consent shall not be unreasonably withheld, and any attempted assignment or delegation in violation thereof shall be void. UNIVERSITY may assign this Agreement at any time to any third party on written notice to RAINDANCE. In the event of an
assignment by UNIVERSITY, the assignee shall be substituted for UNIVERSITY as a party hereto, and UNIVERSITY shall no longer be bound hereby. 

  

	 	G.	Governing Law. The interpretation and performance of this Agreement shall be governed by the laws of the State of Illinois. 

  

	 	H.	Independent Contractors. The Parties agree that the relationship of UNIVERSITY and RAINDANCE established by this Agreement is that of independent contractors. Furthermore, the Parties agree that this Agreement
does not, is not intended to, and shall not be construed to, establish a partnership or joint venture, and nor shall this Agreement create or establish an employment, agency or any other relationship. Neither Party shall have any right, power or
authority, nor shall they represent themselves as having any authority to assume, create or incur any expense, liability or obligation, express or implied, on behalf of the other Party, or otherwise act as an agent for the other Party for any
purpose. 

  

	 	I.	No Use of Name. RAINDANCE agrees not to use, and shall prohibit its Sublicensees and Affiliates of either from using, the name of UNIVERSITY in any commercial activity, marketing, advertising or sales brochures
except with the prior written consent of UNIVERSITY, which consent may be granted or withheld at UNIVERSITY’S sole discretion. RAINDANCE agrees not to use, and shall prohibit its Sublicensees and Affiliates of either from using, the name of any
UNIVERSITY employee(s) in any commercial activity, marketing, advertising or sales brochures. 

  

	 	J.	Waiver. No term or provision of this Agreement shall be waived and no breach excused unless such waiver or consent shall be in writing and signed by the Party claimed to have waived or consented. No waiver of a
breach shall be deemed to be a waiver of a different or subsequent breach. 

  

	 	K.	Construction. Each Party has consulted counsel of their choice regarding this Agreement, and each acknowledges and agrees that this Agreement shall be construed without regard to the Party or Parties responsible
for the preparation of the same and shall be deemed as prepared jointly by the Parties. Any ambiguity or uncertainty existing herein shall not be interpreted or construed against any Party. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	 	L.	Execution. This Agreement may be executed by the Parties in any number of identical counterparts, each of which, for all purposes shall be deemed to be an original, and all of which shall constitute,
collectively, one instrument. 

  

	 	M.	Severability. If any provision of this Agreement shall be held illegal, unenforceable, or in conflict with any laws of any federal, provincial, state, or local government that may exercise jurisdiction over this
Agreement, the validity of the remaining portions or provisions shall not be affected thereby. 

  

	 	N.	Third Party Beneficiaries. All rights, benefits and remedies under this Agreement are solely intended for the benefit of UNIVERSITY and RAINDANCE, and no other person or entity shall have any rights whatsoever to
(i) enforce any obligation contained in this Agreement; (ii) seek a benefit or remedy for any breach of this Agreement; or (iii) take any other action relating to this Agreement under any legal theory, including but not limited to,
actions in contract, tort (including but not limited to negligence, gross negligence and strict liability), or as a defense, setoff or counterclaim to any action or claim brought or made by the Parties. 

IN WITNESS WHEREOF, the parties hereto have caused this agreement to be executed by their respective duly authorized officers or
representatives on the date first above written. 
  

									
	UNIVERISTY	  		  	RainDance Technologies, Inc.
					
	By:	 	 /s/ Alan Thomas
	  		  	By:	 	 /s/ Christopher McNary

	Alan Thomas	  		  	Christopher McNary
	Director of Technology Transfer, UCTech	  		  	President & CEO
	Date of signature: June 9, 2008	  		  	Date of signature: June 10, 2008

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 SCHEDULE A 

Licensed Patents 
 [****] 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 Amendment No. 1 

This Amendment No. 1 is entered into effective as of April 12, 2013 (the “Amendment No. 1 Effective
Date”), by and between RainDance Technologies, Inc., a Delaware corporation having a principal place of business at 44 Hartwell Avenue, Lexington, MA 02421 (“RainDance”) and The University of Chicago, an Illinois
not-for-profit institution (“University”). Each hereunder may be referred to separately as a (“Party”), or together as the (“Parties”). 

WHEREAS, the Parties are party to a certain license agreement between them dated June 9, 2008 (the “License
Agreement”): and 
 WHEREAS, the Parties wish to amend the License Agreement in certain particulars as specified herein;

 NOW, THEREFORE, the Parties, intending to be legally bound, hereby agree as follows: 

 

	1.	Definition of “Field.” Section 1(D) of the License Agreement is hereby deleted and replaced with the following: 

 

	 	“D.	“Field” means [****], wherein: 

  

	 	(a)	[****] 

 For clarity, and without limiting the foregoing, [****]. 

 

	 	(b)	[****]. 

  

	 	For	reference, University of Chicago [****]. 

  

	2.	Definition of [****]. Section 1(1) of the License Agreement is hereby deleted and replaced with the following: 

“I. [intentionally Omitted]” 
  

	3.	Additional License Grant. Section 2(A) of the License Agreement is hereby amended by adding a second sentence thereto as follows: 

“UNIVERSITY hereby grants to RAINDANCE and its Affiliates a non-exclusive license [****].” 

 

	4.	Amendment to Section 3(B). Section 3(B) of the License Agreement is hereby amended by inserting the words “and non-exclusive license*’ in the first sentence thereof so that it reads as
follows: 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 “B. Royalties. As partial consideration for the exclusive license and
non-exclusive license granted in Section 2 of this Agreement, RAINDANCE shall pay UNIVERSITY a Royalty equal to:” 
  

	5.	Deletion of Section 3(C). Section 3(C) (“Accrued Royalties on Newly Licensed Patents”) of the License Agreement is hereby deleted in its entirety and replaced with the following:

 “C. [Intentionally Omitted]” 

The Parties agree that, notwithstanding the deletion of Section 3(C) in accordance with this paragraph 5, any royalties that would have
accrued under Section 3(C) as a result of the issuance of [****] up to the date of such issuance, [****], shall be paid by RAINDANCE to UNIVERSITY in accordance with the terms of Section 3(C). Such payment may be made pro rata over
a period of [****]. 
  

	6.	Agreements with respect to Section 4. The Parties agree that Section 4 (Diligence) of the License Agreement does not apply with respect to any Licensed Product that, [****], would not be a Licensed
Product. The Parties further agree that the obligations of RAINDANCE under subsection B of Section 4 have been satisfied and that subsection B shall have no further import or effect. 

 

	7.	Amendment to Section 6(B). Section 6(B) of the License Agreement is hereby amended by deleting the first paragraph thereof and replacing such first paragraph with the following: 

[****]. 
  

	8.	Amendments to Section 8. Section 8 of the License Agreement is hereby amended by: 

  

	 	a.	adding, after subsection A thereof, the following subsection Al: 

 “Al.
Representations, Warranties and Covenants of UNIVERSITY. UNIVERSITY hereby represents, warrants and covenants that: 
  

	 	(i)	UNIVERSITY has all rights [****] necessary and sufficient to fully effectuate the license grants set out in Section 2(A) hereof without limitation or encumbrance of any kind. 

 

	 	(ii)	UNIVERSITY has not [****], and UNIVERSITY agrees that it shall not [****].” 

  

	 	b.	amending the First sentence of subsection B thereof by adding at the beginning thereof the words “EXCEPT AS OTHERWISE PROVIDED IN SUBSECTION Al OF THIS SECTION 8,” 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

	9.	Notice to RainDance 

 The portion of Section 9(E) of the License Agreement related
to the copy of notice to RainDance is hereby deleted and replaced with the following: 
 With a Copy to: 

Goodwin Procter LLP 
 Attn:
Mitchell S. Bloom re RainDance Technologies, Inc. 
 53 State Street Exchange Place 

Boston MA 02109 
  

	10.	Replacement of Schedule A 

 Schedule A of the License Agreement is hereby deleted
and replaced with the Attached Schedule A. The Parties agree that, notwithstanding anything to the contrary in the License Agreement, Rain Dance’s obligations with respect to [****]. 

As consideration for this Amendment No. 1, RainDance agrees to pay UNIVERSITY a total of [****] on or before [****]. 

Except as expressly set forth above, all other terms and conditions of the License Agreement shall remain unchanged and continue in full force
and effect. This Amendment No. l amends and is hereby made a part of the License Agreement. All capitalized terms not defined herein have the meaning ascribed to them in the License Agreement. 

The Parties may execute this Amendment No. 1 in counterparts, each of which is deemed an original, but all of which together constitute
one and the same amendment. This Amendment No. l may be delivered electronically or by facsimile transmission, and electronic or facsimile copies of executed signature pages shall be as binding as originals. 

IN WITNESS WHEREOF, the Parties have caused this Amendment No. 1 to be executed by their duly authorized representatives as of the date
first written above. 
 [Remainder of page intentionally left blank] 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 RainDance Technologies, Inc. 
  

			
	By: /s/ S. Roopom Banerjee                	  	
	S. Roopom Banerjee	  	
	President and Chief Executive Officer	  	Date of signature: April 12, 2013

 University of Chicago 
  

			
	By: /s/ Alan Thomas                            	  	
	Alan Thomas	  	
	Director of Technology Transfer	  	Date of signature: April 12, 2013

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 SCHEDULE A 

Licensed Patents 
 [****] 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 SCHEDULE B - Patents Subject to [****] - page 1 

[****] 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 SCHEDULE B - page 2 

The Parties agree that [****] by written agreement between the Parties (including by exchange of emails by representatives of the Parties authorized or
delegated to make such agreements) without the need for formal amendment of this Schedule B. 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 Appendix 1 

[****] 
 [Remainder of this page intentionally
left blank] 

  
 CONFIDENTIAL TREATMENT REQUESTED UNDER
C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]